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ABSTRACT
Genetic variants identified to date by genome-wide association studies only ex-
plain a small fraction of total heritability. Gene-by-gene interaction is one important
potential source of unexplained heritability. In the first part of this dissertation, a
novel approach to detect such interactions is proposed. This approach utilizes penal-
ized regression and sparse estimation principles, and incorporates outside biological
knowledge through a network-based penalty. The method is tested on simulated
data under various scenarios. Simulations show that with reasonable outside biolog-
ical knowledge, the new method performs noticeably better than current stage-wise
strategies in finding true interactions, especially when the marginal strength of main
effects is weak.
The proposed method is designed for single-cohort analyses. However, it is gen-
erally acknowledged that only multi-cohort analyses have sufficient power to uncover
genes and gene-by-gene interactions with moderate effects on traits, such as likely
underlie complex diseases. Multi-cohort, meta-analysis approaches for penalized re-
iv
gressions are developed and investigated in the second part of this dissertation. Specif-
ically, I propose two different ways of utilizing data-splitting principles in multi-cohort
settings and develop three procedures to conduct meta-analysis. Using the method
developed in the first part of this dissertation as an example of penalized regressions,
three proposed meta-analysis procedures are compared to mega-analysis using a sim-
ulation study. The results suggest that the best approach is to split the participating
cohorts into two groups, to perform variable selection for each cohort in the first
group, to fit regular regression model on the union of selected variables for each co-
hort in the second group, and lastly to conduct a meta-analysis across cohorts in the
second group.
In the last part of this dissertation, the novel method developed in the first part is
applied to the Framingham Heart Study measures on total plasma Immunoglobulin
E (IgE) concentrations, C-reactive protein levels, and Fasting Glucose. The effect
of incorporating various sources of biological information on the ability to detect
gene-gene interaction is explored. For IgE, for example, a number of potentially
interesting interactions are identified. Some of these interactions involve pairs in
human leukocyte antigen genes, which encode proteins that are the key regulators of
the immune response. The remaining interactions are among genes previously found
to be associated with IgE as main effects. Identification of these interactions may
provide new insights into the genetic basis and mechanisms of atopic diseases.
v
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1Chapter 1
Introduction
Unlike Mendelian diseases, in which disease phenotypes are largely driven by mutation
in a single gene locus, complex disease and traits are associated with a number of
factors, both genetic and environmental, as well as lifestyle. In addition, while most
Mendelian diseases are rare, many complex diseases are frightfully common, from
asthma to heart disease, hypertension to Alzheimer’s, and Parkinson’s to various
forms of cancer.
Arguably motivated by classical successes with Mendelian diseases and traits, the
study of complex diseases and traits in the modern genomics era has focused largely on
the identification of individually important genes. Genome-wide association studies
(GWAS), the current state of the art, have been central to the discovery of many
genes in various diseases (e.g., (Hindorff et al., 2010)). However, unfortunately, the
vast majority of genetic variants associated with complex traits identified to date
explain only a very small amount of the overall variance of the trait in the underlying
population (Manolio et al., 2009). As a result, most GWAS findings thus far have
had little clinical impact.
Currently, most GWAS are carried out one single nucleotide polymorphism (SNP)
at a time. Typically, for each SNP a model is specified, relating disease status or
disease trait to the SNP plus other potentially relevant covariates. The statistical
significance of each SNP is quantified through the p-value of an appropriate test.
Finally, a multiple testing correction is applied to correct the collection of p-values
2across SNPs. The end result is a list of SNPs declared to be significantly associated
with the disease status or trait of interest, which in turn can be mapped to their closest
genes, although some associations have been found in ‘gene deserts’ (Hindorff et al.,
2010). The single-SNP approach has the important attribute that it is (relatively)
computationally efficient. But it can be severely under-powered because of the small
effect size of most genetic variants identified to date (Hindorff et al., 2010; Manolio
et al., 2009). Additionally, this approach does not adjust for correlation among SNPs,
nor does it extend in a natural manner to search for interactions between markers. In
contrast, multiple regression (i.e., where multiple SNPs are modeled simultaneously)
is a natural alternative. But naive implementation (i.e., incorporating all SNPs of
interest) is both infeasible and undesirable. This is due to various reasons, including
the sheer number of SNPs typically available (e.g., hundreds of thousands to millions),
the comparatively small number of SNPs likely to be associated, and ‘small n, large
p’ problems.
Recently, however, computationally efficient multiple regression strategies for GWAS
have begun to emerge that employ various methods of high-dimensional variable se-
lection (e.g.,(Wu et al., 2009; Ma et al., 2010; Wu et al., 2010; Szymczak et al., 2009;
Logsdon et al., 2010; Ayers and Cordell, 2010; Zhou et al., 2010)). Compared to tra-
ditional single-SNP methods, penalized regression methods have been found to yield
fewer correlated SNPs (Ayers and Cordell, 2010) and to be capable of producing sub-
stantially more power while having a lower false discovery rate (He and Lin, 2011).
Furthermore, regression methods can include SNP by SNP interactions in a natural
manner. However, to date this typically has been done in a greedy, stage-wise fash-
ion, by fitting main effect models first and then restricting attention to interactions
among those effects found significant (Wu et al., 2009; Wu et al., 2010). In addition,
the above work makes limited or no use of supplementary biological information on,
3for example, biological pathways and gene function.
We propose a novel network-guided statistical methodology to facilitate the dis-
covery of gene by gene (GxG) interactions associated with complex quantitative traits
related to human disease, one which addresses both of the short-comings cited above.
Main effects and interaction effects in our model are chosen simultaneously, thus al-
lowing for the possibility of detecting genes for which the marginal main effect is
weak. Variable selection is done through penalized regression using sparse estima-
tion principles. The penalty allows for the incorporation of information on biological
pathways and gene function into the analysis of continuous traits related to human
disease. In doing so, this penalty acts as an informal prior distribution on the set
of possible GxG interactions, which in practice allows the investigator to reduce the
number of interactions examined for the model from the nominal and computationally
prohibitive O((# of SNPs)2) to a more manageable, say, O(# of SNPs).
In Chapter 2, we describe our statistical approach. We introduce the model and
our proposed penalty, describe how biological information is incorporated into the
penalty and explain the optimization algorithm used for model fitting and a strategy
for choosing tuning parameters. The design and results of an extensive simulation
study are also presented in Chapter 2. We examine models with varying degrees of
interactions and penalties reflecting different extents of biological knowledge. Simu-
lations indicate that, given relevant pathway information, our approach performs well
in finding true interactions without losing the ability of detecting main effects, and
can noticeably outperform existing stage-wise methods.
In Chapter 3, we extend our method to the multi-cohort setting. We test and
compare four meta-analysis approaches in simulations, namely procedures A, B, C
and D. Procedure A is the ideal situation that we pool individual data from different
cohorts together and apply our proposed method to the combined dataset. This is
4often not possible in practice due to issues arising from patients’ confidentiality. But it
is a ‘gold standard’ to which other approaches can be compared. Procedure B consists
of splitting cohorts into two groups, performing variable selection on the cohorts in
the first group, conducting regression on the union list of selected variables using
the cohorts in the second group and meta-analyzing the results from the regression
using the second group. Procedure C consists of splitting each cohort into two parts,
performing variable selection using our new method on one part and regressing on
selected terms on the other part, and conducting meta-analysis using result from
regression across all cohorts. Procedure D is a variation of procedure C. In procedure
C, cohorts may regress on different lists of selected variables. However, in procedure
D, we combine all selected terms across cohorts after we perform variable selection
using our new method on the first half of data and regress on the union list using
the second half data for all cohorts. In Chapter 3, simulation studies suggests that
procedure B is the one that performs most closely to procedure A and thus the one
that should be used when conducting meta-analysis using our proposed methodology
in Chapter 2.
In Chapter 4, we apply our proposed methodology to three real data examples in
Framingham Heart Study. We investigated gene by gene interactions along with main
effects for the following traits: total plasma Immunoglobulin E (IgE) concentrations,
C-reactive protein (CRP) levels and Fasting Glucose. The analyses are performed on
SNPs with low linkage disequilibrium (LD). The performance of our method under
moderate LD is also assessed. Different outside biological information (i.e. pathway
databases) are incorporated into the analyses. We also apply the stage-wise method
for interaction investigation, to compare with the results of our method. In Chapter
4, we identify some interesting interactions that may be biological meaningful.
In Chapter 5, we conclude this dissertation with some additional discussion and
5potential future research related to this work.
6Chapter 2
Network-Guided Sparse Regression
Modeling for Detection of Gene by Gene
Interactions
In this chapter, we introduce a novel statistical methodology to detect gene-by-gene
interactions. This method utilizes penalized regression and sparse estimation princi-
ples, and incorporates outside biological knowledge though a network-based penalty.
We will present the performance of this method under various scenarios in simulation
studies and show that this method outperforms stage-wise strategies.
2.1 Methods
2.1.1 Modeling Gene by Gene Interaction
Let Y be a quantitative trait of interest, and let {Xj}pj=1 be p predictors representing
SNPs. To include interactions, we are interested in a model of the form
Y = β0 +
p∑
j=1
βjXj +
∑
k>j
βjkXjk +  (2.1)
where Xjk = XjXk. We expect that both the βj’s and the βjk’s are sparse, since it is
unlikely that there is more than a small fraction of SNPs affecting the phenotype Y,
either as main effects or as interactors.
In practice, p will range from hundreds to millions. Our goal is to fit the high
dimensional model (2.1) to data. When p is large but only a small percentage of
7predictors and interactions are present in the true model, a general approach is to
minimize a penalized regression criterion. Accordingly, we propose to estimate the
coefficients β = ({βj}, {βjk})T in our model using a penalized least-squares criterion.
Let Y = (Y1, . . . , Yn)
T , Xj = (X1j, . . . , Xnj)
T and Xjk = (X1jX1k, . . . , XnjXnk)
T
represent our variables Y , Xj, and Xjk collected over n samples. Our criterion is
then written
β˜ = arg min
β
1
2
∣∣∣∣Y− p∑
j=1
βjXj −
∑
k>j
βjkXjk
∣∣∣∣2 + PW (β) . (2.2)
Penalized linear regression has been found to be a powerful tool for fitting high-
dimensional models, particularly in situations where the nominal number of variables
is large relative to the number of observations (e.g (Bu¨hlmann and Van De Geer,
2011)). In the context of GWAS, typically p  n. Hence, it is impossible to fit a
model with the full set of O(p2) nominal interactions among all p SNPs. However,
the coefficient vector β is expected to be sparse. Therefore, a penalty function that
enforces sparseness can be helpful here, by encouraging the optimization in (2.2) to
find solutions in which a large percentage of the main effects and their interactions
are zero, thus dropping the corresponding terms from the model.
Following standard practice, we wish to include interactions only if their cor-
responding main effects are also included in the model. The construction of the
sparseness penalty PW therefore must be handled with some care, so as to enforce the
resulting hierarchical constraint among coefficients . In addition, we would like our
penalty to allow for the use of biological knowledge (e.g., biological pathways, gene
functional classes, etc.) in fitting the model. We address these two goals by defining
8a penalty of the form
PW (β) =λ1
p∑
j=1
(
w2jj||Xjβj||2 +
∑
k 6=j
w2jk||Xjkβjk||2
)1/2
+ λ2
p∑
j=1
∑
k>j
wjk||Xjkβjk|| ,
(2.3)
where the wjk ≥ 0 are non-negative weights provided by the investigator and W =
[wjk] is used to denote the matrix of weights over all SNP pairs i, j. The values
λ1, λ2 > 0 are tuning parameters.
Our penalty is a generalization of that proposed by (Radchenko and James, 2010)
for the purpose of fitting general types of interaction models. (In (Radchenko and
James, 2010), wjk ≡ 1 for all j, k.) Note that, following those authors, we express
the penalty in un-normalized form. (Standard lasso algorithms, for example, without
interactions, assume ||Xj|| = 1 and hence ||Xjβj||2 = β2j ). It can be shown that
the penalty automatically enforces the hierarchical constraint (i.e., inclusion of main
effects before interactions). Main effects and interactions can be treated differently
by varying λ2 with respect to λ1. The elements of the matrix W are generic and allow
for the possibility of including biological information a priori into the model selection
process. We next describe a manner for doing so, in which network principles are
used in a natural way.
2.1.2 A Network-Based Penalty
Below we describe our construction of the matrix W using information from biological
pathways, although similar constructions may be obtained quite generally using other
common resources (e.g., databases of genes and their biological function, such as Gene
Ontology). Note that W acts as a dissimilarity matrix in PW . Under our construction,
W is defined with respect to a graph showing relationships among SNPs, which in turn
9Figure 2·1: Simple illustration of network representations between
SNPs (S1, S2, S3) and pathways (P1, P2).
Figure 2·2: One mode projection of the three examples in Figure 2·1.
derives from a bipartite graph relating SNPs to pathways. The intuition underlying
our construction is (a) to allow interactions only among SNPs corresponding to genes
that are common to at least one pathway, and (b) to encourage interactions among
those SNP pairs that are common to more pathways.
Let S1, . . . , Sp denote our p SNPs, and P1, . . . , Pm, our m pathways. We define
G to be a bipartite graph, with one set of nodes representing SNPs, and the other,
pathways. An edge in G connects a SNP Si to a pathway P` if that SNP maps
sufficiently close to a gene found in the pathway. We then define GSNP to be the
one-mode projection of G onto the set of SNPs. Figures 2·1 and 2·2 show three toy
examples of graphs G and GSNP , for p = 3 SNPs and m = 2 pathways.
An equivalent representation of the relationship between SNPs and pathways in
the network GSNP is a p×m incidence matrix M , describing which SNPs are linked
to which pathways. For the three examples in Figure 2·1, the corresponding incidence
matrices are
M1 =
 1 01 1
0 1
 M2 =
 1 01 1
1 1
 M3 =
 1 00 1
0 1
 . (2.4)
Similarly, the analogous m ×m (weighted) adjacency matrix is the standard repre-
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sentation of the one-mode projection GSNP . Calling this matrix A, it is related to
the incidence matrix M of the original graph G through the expression A = MMT .
For the three examples shown in Figure 2·1 and Figure 2·2, the adjacency matrices
are
A1 =
 1 1 01 2 1
0 1 1
 A2 =
 1 1 11 2 2
1 2 2
 A3 =
 1 0 00 1 1
0 1 1
 . (2.5)
Finally, we define the dissimilarity matrix W elementwise by setting wjk = 1/ajk.
In the case where ajk = 0, we set wjk = ∞ by convention. Note that the resulting
implication for the optimization in (2.2) is that βjk is set to zero, i.e., the term Xjk
cannot enter the model. Hence, only those pairs of SNPs j, k that share at least one
pathway (i.e., wjk < ∞) may potentially enter the model. As a result, it is possible
to substantially reduce the number of interaction terms considered for entry into the
model, thus making the simultaneous search for main effects and interactions easier
to perform. For example, in the application presented in Section 4, a total of 17,025
SNPs were used, corresponding to nearly 145 million interactions. However, in using
the 186 pathways from the KEGG (Kyoto Encyclopeida of Genes and Genomes)
database to construct our matrix W , this number was reduced to less than 480,000
potential interactions.
We note that there are certainly other ways of constructing the matrix W . For
example, a variation on the procedure described above would be to define wjk = 1 if
ajk > 0, and infinity otherwise. This is equivalent to equipping the graph GSNP with
a binary adjacency matrix and letting wjk = 1/ajk as before, and results in the equal
treatment of all interactions that are allowed to enter the model, regardless of how
many pathways are shared by pairs j, k. In addition, of course, other types of outside
information — if judged relevant — can be used in place of pathways, as mentioned
above.
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2.1.3 Model Selection and Fitting
To perform the optimization in (2.2) we use cyclic coordinate descent, a now-standard
choice for problems such as ours (e.g., (Wu and Lange, 2008; Friedman et al., 2007;
Wu et al., 2009)). As the name indicates, the cyclic coordinate descent algorithm
updates one element of β at a time using coordinate descent principles, while holding
all others fixed, and cycles through all elements until convergence. In our context, the
details of the resulting algorithm parallel those of (Radchenko and James, 2010). We
therefore present only a sketch of the algorithm and relevant formulas here. Detailed
derivation can be found in Appendix, Section A.1.
Consider the estimation of βj. We note that, with respect to this parameter, the
objective function in (2.2) can be written as
1
2
(
Y˜j −Xjβj
)T (
Y˜j −Xjβj
)
+ λ1
(
w2jj||Xjβj||2 +
∑
k 6=j
w2jk||Xjkβjk||2
)1/2
+ Cj
(2.6)
where Y˜j = Y −
∑
6`=j X`β˜` −
∑p
`=1
∑
k>` X`kβ˜`k. Here β˜` is the current value of β`
at this stage of our iterative algorithm, and similarly for β˜`k, while Cj is all of the rest
of the penalty term PW (β) that does not involve βj.
The updates to the estimates β˜j of the main effects βj take the form of a shrinkage
estimate, β˜j = αjβˆj, for αj ∈ [0, 1]. Here βˆj = XTj Y˜j is the solution to the problem
of fitting a regression-through-the-origin for Y˜j on Xj, and the shrinkage parameter
αj is the solution to the equation
αj
(
1 +
λ1w
2
jj
(w2jjX
T
j Xjα
2
j βˆ
2
j + cj)
1/2
)
= 1 , (2.7)
where cj =
∑
k 6=j w
2
jk||Xjkβjk||2. The value αj can be obtained using the Newton-
Raphson method. In the special case where cj = 0, which must be the case when wjk =
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0 for all k 6= j (i.e., SNP j is not allowed to participate in any interactions), equation
(2.7) can be solved in closed-form, yielding αj = (1− λ1wjj / [(XTj Xj)1/2|βˆj|])+.
Now consider the estimation of βjk. Similar arguments show that the iterations
in the cyclic coordinate descent algorithm involve updates of the form β˜jk = αjkβˆjk,
for αjk ∈ [0, 1]. Here βˆjk = XTjkY˜jk /XTjkXjk is the solution to the problem of fitting
a regression-through-the-origin for Y˜jk on Xjk, where
Y˜jk = Y −
p∑
`=1
X`β˜` −
∑
m>`
∑
(`,m)6=(j,k)
X`mβ˜`m .
The shrinkage parameter αjk for interaction terms is the solution to the equation
αjkβˆjk
{
1 + λ1w
2
jk
[
1
(w2jkX
T
jkXjkα
2
jkβˆ
2
jk + c
jk
1 )
1/2
+
1
(w2kjX
T
kjXkjα
2
jkβˆ
2
jk + c
jk
2 )
1/2
]}
= sign(βˆjk)
[
|βˆjk| − λ2wjk(XTjkXjk)−1/2
]
+
,
(2.8)
where
cjk1 = w
2
jjX
T
j Xjβ
2
j +
∑
n6=j,k
w2jnX
T
jnXjnβ
2
jn
and
cjk2 = w
2
kkX
T
kXkβ
2
k +
∑
n6=k,j
w2knX
T
knXknβ
2
kn ,
which again can be computed using the Newton-Raphson method. When cjk1 and c
jk
2
are both zero, αjk can be solved in closed form, yielding
αjk =
{
1− [(2λ1 + λ2)wjk] / [(XTjkXjk)1/2|βˆjk|]
}
+
.
The shrunken estimates of coefficients of predictors and interactions are updated
in the iterative process described above until convergence is achieved. Following
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standard practice, upon termination of our cyclic coordinate descent algorithm we
generate a final estimate of coefficients for those variables Xj and Xjk that were
allowed to enter the model, using ordinary least squares. All corresponding effect-size
estimates and p-values produced by our methodology result from this final step.
For datasets with a small number of predictors {Xj}, the algorithm can be easily
fit as described. But for larger numbers of predictors, we employ a ‘swindle’, in
analogy to that proposed by (Wu et al., 2009) and implemented in Mendel ((Lange
et al., 2001)). The basic idea is to apply the algorithm to a much smaller number, say
k, of pre-screened predictors, and to choose the smoothing parameter(s) such that
only a desired number, say s < k, of predictors Xj enters the model. The Karush-
Kuhn-Tucker (KKT) conditions for our optimization problem are then checked for
the estimate β˜ resulting from our algorithm (augmented with zeros for coefficients
of all predictors eliminated at the pre-screening stage). If the KKT conditions are
satisfied, we are done; if not, we double k and repeat the process. Following (Wu
et al., 2009), we let our initial choice of k be a multiple of s, i.e., k = 10 × s in
the applications we show. Pre-screening consists of sorting the t statistics of fitting
ordinary least-square regression of Y on each predictor Xj separately (i.e., traditional
GWAS) and extracting those predictors with the k largest t statistics. Details can be
found in Appendix, Section A.2.
2.1.4 Choice of Tuning Parameters
In the penalty function PW defined in (2.3), the tuning parameters λ1, λ2 directly
influence the number of variables that enter the final model. In principle these two
parameters may be allowed to vary freely and a cross-validation strategy used to select
the best values. However, this strategy is unrealistic for GWAS, where the number of
SNPs may range into millions. Instead, we employ a strategy that allows investigators
some control in dictating how many variables enter the model, and thereby specify
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the tuning parameters implicitly.
First, we impose a linear relation between the two tuning parameters, i.e., λ2 =
cλ1. Because λ2 is directly involved only in the selection of interaction terms, specify-
ing the constant c may be interpreted as “tuning” the number of interactions relative
to main effects. The tuning parameter λ1 is responsible for the number of main ef-
fects in the model. Since λ1 is essentially a decreasing function of the number of main
effects entered in the model and often investigators have at least some rough expec-
tation of how many SNPs they feel are likely to be associated with their phenotype,
we set λ1 by pre-specifying the number of main effects to include in the final model
(i.e., denoted s above).
Second, calculations show that the relation c ≈
√
σjσk
r
holds, where σ2j = 2pj(1−pj)
is the variance of SNP j coded as the number of minor alleles under the assumption of
Hardy-Weinberg equilibrium; the variance is defined here in terms of the minor allele
frequency pj, and r is the ratio of the thresholds for main effects and interactions
to enter the model within the cyclic coordinate descent algorithm. See Appendix,
Section A.3, for details. We recommend that c be chosen by the user through (a)
specifying a desired ratio r, and (b) knowledge of the distribution of SNP minor allele
frequencies.
By setting the desired number of main effects and the value c, we implicitly specify
the values of the tuning parameters λ1, λ2. A smaller value of c (corresponding to a
larger value of r) means more interactions may enter the model, for a fixed number
of main effects.
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2.2 Simulations
2.2.1 Simulation Study Design
We carried out a simulation study in order to assess (i) the performance of our method
under various interaction scenarios, and (ii) the effect of different choices of the W
matrix in our penalty on our ability to detect interaction. We also compared our
method to the stage-wise selection method proposed by (Wu et al., 2009), which
restricts interaction search to SNPs first declared to have main effects. In each sim-
ulated data set, there are 1000 subjects and 1000 SNPs as predictors. The SNPs are
coded additively (0,1,2), simulated with a minor allele frequency (MAF) of 50%, and
drawn from a Binomial distribution with two trials. Lower MAFs were also investi-
gated (MAF >= 10%, see additional simulation in Section 2.3.4). The quantitative
trait Y is then simulated using the effect SNPs and interactions specified under as-
sumed models. Among the 1000 SNPs, 20 (SNP1-SNP20) have true main effects on
the simulated trait and the remaining 980 have no effect.
To test our method in various interaction situations, we evaluate three different
models:
• Model 1: only 20 main effects with no interaction
• Model 2: 20 main effects + all two way interactions among SNP1-SNP5
• Model 3: 20 main effects + SNP1×SNP2 + SNP3×SNP4 + SNP5×SNP6 + ...
+ SNP19×SNP20
Model 1 has no interactions involved. Models 2 and 3 both have 10 interaction terms
involved, and the interactions are all among true main effects. But in Model 2 there
is one cluster with 5 interacting SNPs, while in Model 3 there are 10 clusters, each
with two interacting SNPs.
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In addition, we explore six different ways to construct the W matrix used in the
penalty. In each case, we allow all SNPs to be evaluated as possible main effects, by
having all ones down the diagonal of W . For the possible interaction terms, coded by
the off-diagonal elements of W , we consider the following additions
• W1: + true interactions in models
• W2: + two way interactions among all true main effects (SNP 1-20)
• W3: + true interactions + random ‘noise’ interactions
• W4: + two way interactions among all true main effects + random ‘noise’
interactions
• W5: + two way interactions among SNPs 1-40 (all true main effects and 20
non-active SNPs)
• W6: + two way interactions among SNPs 1-10,21-30 + two way interactions
among SNPs 11-20,31-40
The matrix W1 is an ideal case. It only allows true interactions built in the model
to enter that model. Note that W1 is different for each of Models 1, 2, and 3. The
matrix W2 introduces some ‘noise’ interactions by allowing all interactions among
true main effects. It is equivalent to a single pathway of SNPs 1-20 and is the same
for all models. The matrix W3 adds random ‘noise’ interactions to W1, while W4 adds
random ‘noise’ interactions to W2. Note that W3 and W4 both vary across models.
The random ‘noise’ interactions are introduced in a manner aimed at mimicking the
interaction structure corresponding to the KEGG (Kyoto Encyclopedia of Genes and
Genomes) database, only some subset of which will likely be relevant to any given
study (and the rest, ‘noise’). Specifically, an additional set of ‘pathways’ (i.e., gene
sets) were defined, in addition to those defined by the models themselves, until a total
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of 20 pathways were formed. To these 20 we then randomly allocated 160 additional
SNPs so that the average number of SNPs per pathway roughly mimicked what is
observed in KEGG. W5 represents a single pathway of SNPs 1-40, similar to W2 but
with more SNPs (20 non-active SNPs) involved. W6 then represents two pathways
with each having 10 active and 10 non-active SNPs. It is similar to W5 in the sense
that the allowed interactions involve SNPs 1-40, but W6 has smaller amount of non-
active interactions.
We chose λ1 by setting the desired number of main effects selected as 25, the value
of λ1 is automatically determined by our program once the value 25 is provided.
This is a natural choice since there are 1000 SNPs in our data and 20 true main
effects in the models. This choice will affect Type I error because at least 5 of
the 25 predictors selected as main effects will be false, but this number is modest
compared to the total of 1000 SNPs and can be easily adjusted by re-setting λ1
according to the investigator’s preference. The parameter c is set to 0.5 (i.e., r = 1.0
under our model). The selected predictors are then ranked by their absolute t-values
resulting from the ordinary least-square fit on the selected predictors for the final
model. By setting a threshold on the rank we choose the number of interactions to
be reported and compare the performance of interaction selection under various W
matrix specifications across a range of thresholds.
2.2.2 Simulation Results
In Figure 2·3, we compare the results under various W matrix specifications, for
Models 2 and 3. We assess the ability to find true interactions by computing the
average false discovery rate of interactions over 100 trials and plotting 1-FDR against
the rank-threshold for selected interactions. As the threshold increases, more inter-
actions get selected and thus FDR increases and the curves have a downward trend.
Examining the results, we see that W1 clearly has the best performance, as it re-
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flect the truth about the interactions in the model; all false interactions are excluded
a priori and thus the 1-FDR curve for W1 is a straight line at 1. Recall that W3
is equivalent to W1 plus random ‘noise’. Importantly, therefore, we note that pure
‘noise’ among non-active SNPs does not appear to impact much the selection of true
interactions, as W3 has the second best performance after W1. This conclusion is re-
inforced by the results for W2 and W4, where the 1-FDR curves are nearly identical.
On the other hand, the results in Figure 2·3 also suggest that selection of interactions
is to some extent adversely affected when allowing ‘noise’ interactions among active
SNPs, as W6 has a better performance than W2 and W5 while W2 and W5 have very
similar performance.
In comparing our method to that of (Wu et al., 2009), as implemented in Mendel,
we can see in Figure 2·3 that our method outperforms stage-wise selection for all
choices considered for the matrix W . This observation is important in showing that
using accurate prior information, even with moderate ‘noise’ (i.e., specifying non-
existent interactions), it is possible to out-perform the stage-wise approach by over
10− 20% on the 1-FDR scale. Note that we used the default option in Mendel that
tests interactions among selected main effects. There are other options in Mendel one
can choose that may perform somewhat better.
With respect to the detection of main effects, the performance of our methodol-
ogy is shown in Table 2.1. The average power of main effects are grouped into three
categories: the true SNPs involved in interaction, true SNPs not involved in interac-
tion and the SNPs that have no effect on the simulated trait. Recall that there is no
interaction in Model 1 and all true SNPs in Model 3 are involved in interaction, so
they have only two relevant groups of SNPs. As we can see from the Model 2 result,
SNPs involved in interactions are detected more easily than SNPs not involved in
interactions. Comparing Table 2.1 to Table 2.2, we can also see that our method
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Figure 2·3: Interaction Results for Model 2 and Model 3 with 6 W
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has the same or higher average power to detect true main effects than the stage-wise
approach of (Wu et al., 2009), as implemented in Mendel. In both approaches the
non-active SNPs have a very small chance of being selected as main effects.
The results just described correspond to simulations of our models where the effect
sizes of main effect and interaction were set for 80% power at a type I error rate of
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Model 1
Main Effects W1 W2 W3 W4 W5 W6
SNPs w/ Inter-
action
- - - - - -
SNPs w/o Inter-
action
0.618 0.645 0.616 0.645 0.645 0.636
Non-active
SNPs
0.013 0.012 0.013 0.012 0.012 0.012
Model 2
Main Effects W1 W2 W3 W4 W5 W6
SNPs w/ Inter-
action
1.000 1.000 1.000 1.000 1.000 1.000
SNPs w/o Inter-
action
0.565 0.607 0.565 0.607 0.606 0.595
Non-active
SNPs
0.011 0.011 0.012 0.011 0.011 0.011
Model 3
Main Effects W1 W2 W3 W4 W5 W6
SNPs w/ Inter-
action
1.000 1.000 1.000 1.000 1.000 1.000
SNPs w/o Inter-
action
- - - - - -
Non-active
SNPs
0.005 0.005 0.005 0.005 0.005 0.005
Table 2.1: Simulation results for detection of main effects.
Main Effects Model 2 Model 3
SNPs w/ Inter-
action
1.000 1.000
SNPs w/o Inter-
action
0.557 -
Non-active
SNPs
0.012 0.005
Table 2.2: Detection of main effects by stage-wise competitor.
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5% under standard single-SNP models with additive-trait structure and SNPs with
50% MAF. Our approach performed similarly with common SNPs with lower MAF
(MAF >= 10%) and equivalent power, see Section 2.3.4 Figure 2·8. We also test
two more cases where main effect sizes were moderate and weak, corresponding to
50% power and 20% power, respectively. To assess the performance of our method
in finding interactions under these various strengths of main effects, we reverse the
direction of interactions so that there is no marginal SNP effects. The W matrix
we used is W2, as described before, to make a fair comparison with respect to the
inclusion of noise interactions. The results under such models are shown in Figure
2·4. As we can see from the figure, the approach implemented using Mendel could
not find true interactions under any of the models (the regular (Mendel), the moder-
ate (Mendel.moderate) and the weak (Mendel.weak) main effect models), as it only
searches for interactions among main effects selected in the first stage. In contrast,
our proposed approach is able to find some of the true interactions because it in-
corporates information from the W matrix, the network of interactions built from
outside knowledge. Not surprisingly, the model with stronger main effect (M2W2,
M3W2) performs better in finding true interactions than moderate (M2W2.moderate,
M3W2.moderate) or weak (M2W2.weak, M3W2.weak) main effect models.
2.3 Additional Simulations
There are a variety of additional questions that we explored computationally. In this
section we present the results of four additional simulations.
2.3.1 Comparison with Simple Association Tests
To compare our approach to some simple association tests, we implement two ad-
ditional methods in simulation. First, we implement a method that tests all main
effects using simple linear regression (one SNP at a time) and tests all interactions
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Figure 2·5: Interaction Results for Model 2 with W4 for our proposed
method vs. simple association tests.
Main Effects Our approach Simple test 1 Simple test 2
SNPs w/ Interac-
tion
1.000 1.000 1.000
SNPs w/o Interac-
tion
0.607 0.251 0.251
Non-active SNPs 0.011 0.017 0.017
Table 2.3: Detection of main effects: Our approach vs. two simple
association tests.
within the network (i.e., allowed in W matrix) with their main effects. Second, we
implement a method that tests all main effects, ranks them based on p-values, and
selects the first 25(i.e., the same number as our approach), after which interactions
within the selected SNPs are tested, among those that are also allowed by the W
matrix. These two approaches and our proposed method are applied to Model 2
with W4. Tuning parameters for our method are chosen in the same way as before
(i.e., setting λ1 implicitly be specifying 25 main effects be selected, and setting the
parameter c to 0.5). Results are shown in a 1-FDR plot.
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Main Effects Analysis with 1000 SNPs Analysis with 10,000 SNPs
SNPs w/ Interac-
tion
1.000 1.000
SNPs w/o Interac-
tion
0.607 0.309
Non-active SNPs 0.011 0.002
Table 2.4: Detection of main effects: Analysis with 1000 SNPs vs.
Anslysis with 10,000 SNPs.
As we can see from Figure 2·5, the second method performs better than the first
one in finding true interactions. However, it is also very clear that our proposed
approach outperforms both of the methods in finding true interactions and main
effects (Table 2.3).
2.3.2 Stability of Detection with Larger Numbers of SNPs
Because of the multitude of conditions we explored through simulations in Section
2.2, and for reasons of computational expediency, we chose to use p = 1000 SNPs
in our models. However, in practice, substantially larger numbers of SNPs will be
used. One relevant question to examine is whether the detection levels found through
simulations with 1000 SNPs remain stable for larger numbers of SNPs.
In order to explore this question, we perform additional simulations for 10,000
SNPs, where 9000 additional ’noise’ SNPs are added in the simulated data. The
simulation is conducted for Model 2, with W4. The tuning parameters are chosen
in the same way as before (i.e., setting λ1 implicitly by specifing 25 main effectsbe
selected, and setting the parameter c to 0.5).
Our results show that, as expected, with a greater number of ’noise’ SNPs, it is
harder to find true main effects (lower percentage of finding true main effects, shown
in Table 2.4). However, interestingly, our results also show that, if anything, there is
a slightly higher rate of true discoveries among declared interactions. This perhaps
surprising result can be explained as follows. As we mentioned in Section 2.2.2,
pure ’noise’ interactions among ’noise’ SNPs does not have a large impact on the
24
10 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
1−FDR vs. Rank Threshold for M2W4
Rank Threshold
1−
FD
R
M2W4_1000SNPs
M2W4_10000SNPs
Figure 2·6: Comparison of Interaction Results for Model 2 with W4:
1000SNPs vs. 10000SNPs .
selection of true interactions, but allowing ’noise’ interactions among active SNPs
adversely affects the selection of true interactions. At the same time, the number of
true interactions selected remained roughly constant in scaling from 1000 to 10,000
SNPs. Hence the rate of true discoveries among interactions is slightly higher. See
Figure 2·6.
2.3.3 The Relative Importance of Network Information
Note that the penalty used in our method accomplishes two goals simultaneously: it
enforces a hierarchical constraint on the inclusion of terms in the model (i.e., interac-
tions after main effects), and it uses network information to restrict which interactions
are considered. To evaluate the relative importance of enforcing hierarchical structure
versus incorporating network information, we performed a simulation with W = IIT ,
(I = (1, 1, . . . , 1)T ) – where the network information is ignored and all interactions
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are allowed, compared to a W matrix incorporated some network information (i.e.,
on top of enforcing hierarchical structure). Because the assessment of interactions
among all SNPs is computationally burdensome, we perform this simulation on a
reduced version of the model. Specifically, we simulate 100 SNPs with 10 true main
effects (SNP1-10). The interaction structure is the same as Model 2 (all two way
interactions among SNP1-5).
Three analyses are compared:
1. Wall = II
T : network information ignored, all possible interactions are allowed
2. Wfirst10: two way interactions among all true main effects (SNP1-10), similar
to W2 when we had 20 true main effects
3. Mendel : step-wise approach that test interactions among selected main effects
(default option in Mendel)
The last method (i.e., Mendel) is the same as described before, and is included here
simply for comparison.
Comparing the result with network information ignored (hierarchical feature re-
tained, M2 W.all in Figure 2·7) and the result with network information incorporated
(M2 W.first10 in Figure 2·7), the 1-FDR curve shows that the latter has a better per-
formance in finding true interactions. Also by allowing all interactions, the computing
time is dramatically increased. The approach implemented in Mendel (default op-
tion) performs better than the analysis with no network information, in finding true
interactions when the rank threshold is small (the first few selected interactions have
higher percentage of being true), and is also close to the performance of the analysis
with network information. When the rank threshold increases (looking at selected
interactions further down the list), Mendel performs worse than the analysis with
network information and closer to the results without network information. This
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Model 2 Model 3
Main Effects W2 W3 W4 W2 W3 W4
SNPs w/ Interac-
tion
1.000 1.000 1.000 0.993 0.993 0.992
SNPs w/o Interac-
tion
0.630 0.587 0.629 - - -
Non-active SNPs 0.011 0.011 0.011 0.005 0.005 0.005
Table 2.5: Detection of main effects: Analysis of SNPs with varying
MAF.
phenomenon makes sense because the approach in Mendel also has a hierarchical
property (searching for interactions among selected main effects).
2.3.4 Performance with Varying Minor Allele Frequencies
Although the SNPs were simulated with minor allele frequency (MAF) of 50%, we
perform additional simulation to explore the robustness of our approach when MAF
varies. The MAFs of 10%, 20%, 30%, 40% and 50% are randomly assigned to non-
active SNPs. They are also each assigned to 4 of 20 true SNPs (MAF=10% for SNP1,
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6, 11, 16; MAF=20% for SNP2, 7, 12, 17; MAF=30% for SNP3, 8, 13, 18; MAF=40%
for SNP4, 9, 14, 19; and MAF=50% for SNP5, 10, 15, 20). SNPs are coded additively
and simulated under a Binomial distribution with two trials, as before. Keeping the
effect sizes of main effects and interactions corresponding to the same power (80%)
as before, we tested Model 2 and Model 3 with W matrices W2, W3 and W4 and
compared to the result of analysis with MAF of 50%, in Figure 2·8. As we can
see from Figure 2·8 (for interaction result) and Table 2.5 (for main effect result),
the analysis of SNPs with varying MAF has a similar performance compared to the
analysis with MAF=50%
2.4 Discussion
There are many potential sources of missing hereditability. Gene-by-gene interactions
is one potential source. In turn, there are many types of genetic interactions, including
multiplicative and non-multiplicative (Mukherjee et al., 2008; Mukherjee et al., 2012).
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In this chapter, we focus on investigating multiplicative interactions in the form of
a product between two variables. Our proposed methodology provides a promising
new approach to identify such interactions, by exploiting the wealth of biological
knowledge accumulated in various pathway databases.
The simulations reported in Section 2.2 suggest that our approach performs better
in finding true interactions with a reasonable prior biological knowledge incorporated,
compared to the stage-wise regression method that first fits a main effect model and
then searches for interactions among selected main effects. The ability of finding true
main effects is retained, as compared to the stage-wise approach.
Furthermore, the additional simulations reported in Section 2.3 show that (1) our
approach outperforms simple association tests; (2) scaling up data size by adding more
‘noise’ SNPs makes it harder to find true main effects but does not adversely affect
the selection of interactions; (3) using network information in our penalty results
in decreasing computing time, and also yields advantages in detecting interactions
beyond the advantage derived from the hierarchical nature of the penalty; and (4)
our approach with varying MAF has a similar performance to the one with constant
MAF.
We implemented our proposed method in R and the code is available at
http://math.bu.edu/people/kolaczyk/software
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Chapter 3
Extension to Multiple Cohorts:
Meta-Analysis Approaches
3.1 Motivation
Meta-analysis is a general approach to combine results from multiple cohorts and is
routinely used in Genome Wide Association Studies (GWAS). To increase power to
detect true signals, multiple studies are combined to increase sample size. Individ-
ual level data usually cannot be pooled among studies because of restrictions due to
subjects’ confidentiality, so meta-analysis approaches are often used to combine sum-
mary statistics across studies. Widely used meta-analysis approaches include Fisher’s
method (Fisher, 1925; Mosteller and Fisher, 1948), Stouffer’s Z-score method (Stouf-
fer et al., 1949) and inverse variance method using fixed effect model (Hartung et al.,
2008; Willer et al., 2010). These methods require valid p-values or β and SE estimates
of participating studies.
Penalized regression is an effective multivariate approach to select important pre-
dictors in GWAS. However, it doesn’t provide p-values, because the β estimates are
shrunk due to the penalty involved in optimization and they are used for variable se-
lection (depending on if the term being considered has a non-zero coefficient estimate
or not) instead of effect size estimation (Wasserman and Roeder, 2009; Meinshausen
et al., 2009).
To extend our proposed methodology to multi-cohort setting, we need to tackle
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two issues. The first is to obtain valid p-values. Ordinary least squares are often used
to obtain p-values or effect size estimation (β). But regular regression with selected
terms cannot be applied to the same set of data that has been used for variable
selection. Recent articles have been focused on data-splitting method to obtain p-
values for high-dimensional data. (Wasserman and Roeder, 2009) proposed splitting
the observations into two subsets, using one subset for variable selection and using the
other subset to obtain valid p-values. (Meinshausen et al., 2009) further suggested
multiple splits instead of single split, because the result of single split highly depends
on the arbitrary split. We employ data splitting method to obtain p-values for our
method proposed in Chapter 2.
The second challenge is to develop an appropriate procedure to meta-analyze
across the cohorts. We propose two extensions to the splitting method for meta-
analysis: splitting within cohort and splitting cohorts. The first approach involves
splitting data for each cohort, selection of variables on one subset and computation of
p-values on the other subset, and finally a meta-analysis across all cohorts. This is a
natural extension of our method and splitting method to multiple cohorts. The second
approach involves splitting cohorts instead. Cohorts are split into two groups, one
group used for variable selection and the other used for obtaining p-values and meta-
analysis. This is a more practical approach because it simplifies the communication
process among different studies and reduces the possibility of making errors.
3.2 Methods: Pooling Data Across Studies
Based on the discussion above, we propose to examine four procedures for combining
data across multiple cohorts. The variable selection method used should be the same
for all of the following four procedures. In our current work, we used the method we
proposed in Chapter 2. But the procedures we proposed here for meta-analysis are
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applicable, in principle, to general penalized regression methods of the form
Y = β0 +
p∑
j=1
βjXj +  (3.1)
where β is estimated through a penalized least-squares criterion.
β˜ = arg min
β
1
2
∣∣∣∣Y− p∑
j=1
βjXj
∣∣∣∣2 + PW (β) . (3.2)
where PW is a function of coefficient β. And the theoretical justification for the case of
penalized regression with the classical Lasso has already been provided (Wasserman
and Roeder, 2009; Meinshausen et al., 2009).
Again similar to Chapter 2, in model (3.1) the variables Xj are SNPs (coded as
number of minor alleles 0, 1, 2). The goal of the variable selection method is to
identify a small set of SNPs that explain the dependent variable Y . After variable
selection, we estimate p-values (or equivalently β and SE) using data-splitting method
(each procedure has a different way of splitting data in multi-cohort setting).
As mentioned earlier, there are several different ways of conducting meta-analysis
in a regular regression framework. Fisher’s method (Fisher, 1925; Mosteller and
Fisher, 1948) provides a way of combining p-values across studies, but it doesn’t take
into account the direction of the effects. Stouffer’s Z-score method (Stouffer et al.,
1949) solved this problem by using Z-scores instead of p-values. And this is the reason
that in the following four procedures we obtain Z-scores instead of p-values.
Unlike Fisher’ method and Stouffer’s Z-score method, the inverse variance based
method (Hartung et al., 2008; Willer et al., 2010) estimate β coefficient (effect sizes)
and SE in addition to Z-scores (or equivalently p-values). But not all of the procedures
can utilize this method depending on their different data-splitting scheme. So we
obtain β and SE when available (Z-scores otherwise) out of data-splitting and regular
regression steps, and use these as the input for meta-analysis (inverse variance based
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method when β and SE are available, Stouffer’s Z-score method otherwise). And the
result of the meta-analysis will be a set of β and SE (or Z-scores) for selected terms
in the variable selection step (β = 0 or Z = 0 for terms not selected). You may
also choose to obtain p-values from the final result of the meta-analysis. But in our
work, we choose to show the result in Z-scores because it provides effect direction.
Different variations on our data-splitting principle are described in the following four
procedures.
3.2.1 Procedure A: Ideal Situation, the Mega-Analysis
When analyzing data from multiple studies involved in a consortium, the ideal strat-
egy would be to pool individual data together and conduct analysis as one dataset.
Although not practical, it is a ‘gold standard’ when comparing other procedures.
And our goal is to find the meta-analysis procedure that behaves most similarly to
the mega-analysis. We use the following algorithm to conduct Procedure A, the
mega-analysis.
1. For k = 1, 2, . . . , K, where K is the number of splits,
(a) Randomly split the pooled data into two parts D
(k)
1 and D
(k)
2 of equal size.
(b) i. Run our selection method using only D
(k)
1 .
ii. Select s SNPs and interactions.
(c) i. Using only D
(k)
2 , fit linear regression with the selected predictors (main
effects and interactions) from D
(k)
1 .
ii. Obtain p-values for selected predictors.
iii. Set p-values to 1 for unselected predictors.
(d) i. Adjust p-values using Bonferroni correction (divide the original p-
values by the number of selected predictors).
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ii. Convert adjusted p-values to corresponding Z values using standard
normal distribution.
2. Average Z scores over K sets of results.
3.2.2 Procedure B: Split Cohorts into Two Groups
A more practical extension of the splitting method is to split the cohorts into two
groups. We select variables using cohorts in the first group, then calculate p-values/Z
scores and conduct meta-analysis using cohorts in the second group. This is a two-
step procedure. In the first step, all cohorts run our method to select variables and
report back their selected predictors. Then the meta-analysis center randomize the
cohorts into two groups K times (let K be the number of splits) and create K union
lists of selected predictors using results reported by cohorts in the first group. In the
second step, cohorts are asked to fit final models at most K times, according to the
number of times them being assigned to the second group.
This approach makes it easier for individual studies to perform the necessary anal-
yses, and simplify the overall communication process among studies. The algorithm
for Procedure B is described below.
1. For all cohorts m = 1, 2, . . . ,M , run our method to select predictors.
2. For k = 1, 2, . . . , K,
(a) Randomly split cohorts into two equal groups {set(k)1 } and {set(k)2 } (each
set contains equal number of cohorts)
(b) Use the selected SNPs and interactions from {set(k)1 } to create a common
list (union) of predictors for the current split.
(c) i. Run linear regression for the common list of predictors on {set(k)2 }
cohorts.
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ii. Obtain β coefficients and SE for predictors on the union list.
(d) i. Conduct meta-analysis using β and SE across {set(k)2 } cohorts.
ii. Calculate Z = β/SE for predictors on the union list and let Z = 0 for
unselected predictors.
3. (a) Average Z scores over K splits.
(b) Calculate p-values assuming Z follows standard normal distribution.
(c) Adjust p-values using Bonferroni correction and convert p-values back to
Z values.
3.2.3 Procedure C: Split Each Cohort into Two Parts
The data splitting method (Wasserman and Roeder, 2009; Meinshausen et al., 2009)
suggests splitting the data into two equal subsets, selecting variables using one subset
and obtaining valid p-value using the other subset. A natural extension of this method
to multiple-cohorts setting is to split data for each cohort and perform meta-analysis
using results from each cohort. The following algorithm describes this approach.
1. For cohort m, m = 1, . . . ,M ,
(a) For k = 1, 2, . . . , K, where K is the number of splits,
i. Randomly split the data of cohort m into two parts D
(k)
m1 and D
(k)
m2 of
equal size.
ii. A. Run our selection method using only D
(k)
m1.
B. Select s SNPs and interactions.
iii. A. Using only D
(k)
m2, fit linear regression with selected predictors (main
effects and interactions) from D
(k)
m1.
B. Obtain p-values for selected predictors.
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C. Set p-values to 1 for unselected predictors.
D. Convert p-values to corresponding Z values in standard normal
distribution.
(b) Average Z scores for cohort m over K sets of results.
2. Conduct meta-analysis using Z scores across M cohorts.
3. (a) Adjust for multiple testing.
(b) Convert the Z scores (result from meta-analysis) to p-values, adjust p-
values using Bonferroni correction, and convert them back to Z scores.
3.2.4 Procedure D: A Variation of Procedure C
This approach is a variation of Procedure C. In procedure C, each study conducts
analysis (variable selection and p-values computation) separately without shared in-
formation. The information is aggregated in the last step, the meta-analysis. It is
possible and highly likely that the selected predictors and interactions are different
among studies. Non-selected predictors are assigned zero Z scores (or equivalently,
p-value of 1). While in Procedure B, there is shared information before obtaining
p-values. The list of selected terms is the union of all selected variables in the first
group. To see if the sharing of information makes a difference, we modify Procedure C
so that there is information sharing before obtaining p-values. We name the modified
version Procedure D.
As we will see in the following description, after variable selection is completed by
each cohort on the first half of their data, a union list of all selected terms is created
and shared among all cohorts. All the cohorts obtain p-values using the same selected
terms on their second half data.
This procedure is even less practical than Procedure C and increases the chal-
lenge in the communication process among studies. The main purpose of examining
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this procedure is to find out if the information sharing makes Procedure C perform
differently from Procedure A and B. The algorithm for Procedure D is described
below.
1. For k = 1, 2, . . . , K,
(a) For cohort m, m = 1, . . . ,M ,
i. Randomly split the data of cohort m into two parts D
(k)
m1 and D
(k)
m2 of
equal size.
ii. A. Run our selection method using only D
(k)
m1.
B. Select s SNPs and interactions.
(b) Obtain union set of selected terms based on Dm1 for all m.
(c) For cohort m, m = 1, . . . ,M ,
i. Using only D
(k)
m2, regress on the union set of selected terms.
ii. Obtain β and SE for predictors in the union set.
(d) i. Conduct meta-analysis for β and SE across M cohorts.
ii. Calculate Z = β/SE for predictors in the union set and let Z = 0 for
unselected predictors.
2. (a) Average Z scores over K splits.
(b) Calculate p-values assuming Z follows standard normal distribution.
(c) Adjust p-values using Bonferroni correction and convert p-values back to
Z values.
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3.3 Simulation
3.3.1 Simulation Study Design
We conduct a simulation study to compare the performance of all four procedures.
Procedure A is the ideal case (mega-analysis), which is what would happen if the
datasets from all cohorts could be pooled together and analyzed as one dataset. So
our goal is to find the procedure that has similar performance to procedure A.
There are M = 10 cohorts in our multi-cohort simulation. We used a similar data
generating process as we used in Chapter 2, which we outline below.
Each dataset (cohort) has 1000 subjects and 1000 SNPs as predictors. The SNPs
are coded additively (0,1,2), simulated with a minor allele frequency (MAF) of 50%,
and drawn from a Binomial distribution with two trials. The quantitative trait Y is
then simulated using the effect SNPs and interactions specified under the assumed
models. Among the 1000 SNPs, 20 (SNP1-SNP20) have true main effects on the
simulated trait and the remaining 980 have no effect. The models and W matrices
are the same as in Chapter 2.
We evaluate two models:
• Model 2: 20 main effects + all two way interactions among SNP1-SNP5
• Model 3: 20 main effects + SNP1×SNP2 + SNP3×SNP4 + SNP5×SNP6 + ...
+ SNP19×SNP20
and five different ways to construct the W matrix used in the penalty: all SNPs
as possible main effects +
• W2: + two way interactions among all true main effects (SNP 1-20)
• W3: + true interactions + random ‘noise’ interactions
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• W4: + two way interactions among all true main effects + random ‘noise’
interactions
• W5: + two way interactions among SNPs 1-40 (all true main effects and 20
non-active SNPs)
• W6: + two way interactions among SNPs 1-10,21-30 + two way interactions
among SNPs 11-20,31-40
3.3.2 Simulation Result
The simulation results are summarized in terms of Z scores for all predictors and
interactions averaging over 100 simulations. The matrix plots have four columns, each
representing one procedure A, B, C, D, in that order. Within each plot, the results
under 5 W matrix specifications are shown. Each row of the matrix plots represent one
group of predictors/interactions. As shown in Figure 3·1, predictor and interactions
are categorized into 5 groups for Model 2: active SNPs involved in interactions,
active SNPs not involved in interactions, non-active SNPs, true interactions, noise
interactions. In Figure 3·2 of Model 3 , predictors and interactions are categorized
into 4 groups: active SNPs, non-active SNPs, true interactions, noise interactions,
because all active SNPs are involved in true interactions.
Comparing results from all procedures for each group of predictors/interactions,
Procedure B is the one that performs most closely to Procedure A. There is an
obviously difference in patterns between Procedures B and C, when comparing them
to Procedure A. When the true main effects are also involved in true interactions,
Procedure C tends to select main effects rather than interactions. In Figure 3·1,
Procedure C has very high Z values for SNP1-5 while very low Z values for true
interactions, which is exactly the opposite to the performance of Procedure A and B.
Procedure C also has low Z values for active SNPs 6-20 not involved in interactions.
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By modifying Procedure C to share information before obtaining valid p-values (i.e.
Procedure D), the performance of Procedure D is much closer to that of Procedure
A, although still not as close as Procedure B. This is an interesting phenomenon since
Procedure B is also the most practical procedure.
The same conclusion holds for Model 3, in Figure (3·2).
We also test all the procedures using single split. The results of Z scores averaging
over 100 simulations are shown in Figure 3·3 for Model 2 and Figure 3·4 for Model 3.
As we can see, the observations from Figure 3·1 and 3·2 also hold in these two figures.
Procedure B is the one that performs most closely to Procedure A, what should be
expected if data of all cohorts were merged together and analyzed as one dataset. Also,
Procedure C performs differently from Procedure A and B when selecting interactions
involving main effects. This difference reflects the same pattern we observe in the
multiple splits. And by adding information sharing in Procedure C (i.e. Procedure
D), it performs much more closely to Procedure A, although not as close as Procedure
B.
When comparing single split vs. multiple splits, we examine the standard errors
of the Z scores. As (Meinshausen et al., 2009) pointed out, multiple splits method
is better than single split because the result of single split depends on the arbitrary
split chosen. We present the standard errors of Z scores for multiple splits in Figure
3·5 and 3·6 for Models 2 and 3, single split in Figure 3·7 and 3·8 for Models 2 and 3,
respectively. By comparing Figure 3·5 and Figure 3·7, we can see that single split has
a much larger standard error of Z scores compared to multiple split, meaning that
the result of single split is more variable, which is consistent with what (Meinshausen
et al., 2009) suggested. Comparison of Figure 3·6 to Figure 3·8 for Model 3 leads to
the same conclusion.
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Figure 3·1: Multi-split Model 2: Average Z values for Procedure A, B,
C, D with 5 W matrices. Predictors/interactions are categorized into 5
groups: active SNPs involved in interactions, active SNPs not involved
in interactions, non-active SNPs, true interactions, noise interactions
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Figure 3·2: Multi-split Model 3: Average Z values for Procedure A,
B, C, D with 5 W matrices. Predictors/interactions are categorized
into 4 groups: active SNPs, non-active SNPs, true interactions, noise
interactions
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Figure 3·3: Single-split Model 2: Average Z values for Procedure A, B,
C, D with 5 W matrices. Predictors/interactions are categorized into 5
groups: active SNPs involved in interactions, active SNPs not involved
in interactions, non-active SNPs, true interactions, noise interactions
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Figure 3·4: Single-split Model 3: Average Z values for Procedure A,
B, C, D with 5 W matrices. Predictors/interactions are categorized
into 4 groups: active SNPs, non-active SNPs, true interactions, noise
interactions
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Figure 3·5: Multi-split Model 2: Standard error of Z values for Pro-
cedure A, B, C, D with 5 W matrices. Predictors/interactions are
categorized into 5 groups: active SNPs involved in interactions, active
SNPs not involved in interactions, non-active SNPs, true interactions,
noise interactions
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Figure 3·6: Multi-split Model 3: Standard error of Z values for Proce-
dure A, B, C, D with 5 W matrices. Predictors/interactions are cate-
gorized into 4 groups: active SNPs, non-active SNPs, true interactions,
noise interactions
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Figure 3·7: Single-split Model 2: Standard error of Z values for Pro-
cedure A, B, C, D with 5 W matrices. Predictors/interactions are
categorized into 5 groups: active SNPs involved in interactions, active
SNPs not involved in interactions, non-active SNPs, true interactions,
noise interactions
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Figure 3·8: Single-split Model 3: Standard error Z values for Proce-
dure A, B, C, D with 5 W matrices. Predictors/interactions are cate-
gorized into 4 groups: active SNPs, non-active SNPs, true interactions,
noise interactions
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3.4 Discussion
We examined four procedures to conduct meta-analysis using our method proposed
in Chapter 2. The simulations showed that Procedure B is the one that performs
most closely to the ideal case (i.e. when data are merged together and analyzed
as one dataset). Modifying Procedure C to allow information sharing improves its
performance to be closer to Procedure A, but still not as close as Procedure B is.
We compared the multiple splits and single split methods in simulations. Both
of them showed that Procedure B has the most similar performance as Procedure
A, compared to the other two procedures. But the multiple splits method is clearly
better than the single split approach, in terms of the stability of the result.
Another interesting thing we observe here is that Procedure B is the preferred
procedure in terms of performance, but is also the most practical strategy among the
three procedures B, C and D. Although we already showed that multi-split is better
than single split, it is a complicated process to implement multi-split in Procedure
C and D. In Procedure C and D, each cohort has to split their own data K times,
assuming K is the number of splits. The variable selection and p-value estimation are
done within each cohort. This will be very complicated to coordinate among studies,
and is an error-prone process. On the other hand, if we look back the algorithm of
Procedure B, we can find that it is much easier to implement multi-split in Procedure
B. All cohorts perform the variable selection analysis only once and report to the
meta-analysis center, where the data-splitting is done K times randomly. According
to the K assignment of groups, results of cohorts in the first group are pooled and
used to create K union lists of selected terms. The K lists are sent to the cohorts in
the second group, according to the corresponding K assignments. And these cohorts
are asked to perform a final model fitting. Each cohort will be asked to perform the
final fitting at most K times.
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We expect that the conclusions presented here should be relevant to a variety of
other Lasso-based methods more generally. As we didn’t use any exclusive features of
our method when developing the meta-analysis strategies, our methods are applicable
generally. And it is an interesting direction for future study to apply the meta-analysis
approaches to other Lasso-based method.
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Chapter 4
Real Data Applications
In this chapter, we apply our proposed methodology to three real data examples from
the Framingham Heart Study. We will show that our method is effective in identifying
potentially interesting interactions in these applications.
4.1 Application to IgE Concentration
We applied our algorithm to evaluate gene-by-gene interactions for log plasma IgE
concentration, a biomarker that is often elevated in individuals with allergy to envi-
ronmental allergens. An elevated plasma IgE concentration is associated with allergic
diseases including asthma, allergic rhinoconjunctivitis, atopic dermatitis, and food al-
lergy. Although several genes influencing IgE concentrations have been identified to
date, the interaction among these genes or others yet to be identified to be important
players have not been studied (Granada et al., 2012).
We sought to investigate gene-by-gene effects on log IgE concentration in the
Framingham Heart Study (FHS) cohorts. Participants from the town of Framing-
ham, Massachusetts have been recruited in these studies starting in 1948, and have
been followed over the years for the development of heart disease and related traits,
including pulmonary function and allergic response measured by IgE concentration.
Our analyses include 6975 participants, 441 from the original cohort recruited in 1948,
an additional 2848 from the Offspring cohort recruited in 1971, and finally 3686 par-
ticipants from the third generation cohort initiated in 2002. A recent genome-wide
51
association study on Framingham participants identified new genetic loci associated
with plasma total IgE concentrations (Granada et al., 2012). We are interested in
looking at GxG interactions associated with IgE concentration, as an illustration of
our methodology.
4.1.1 Preliminaries
Genotypes were from Affymetrix 500K and MIPS 50K arrays, with imputation per-
formed using HapMap 2 European reference panel (Li et al., 2010). Dosage genotypes
(expected number of minor alleles) were used in our analysis, although the software
implementation of the (Wu et al., 2009) approach (Mendel) required genotypes to
be coded as 0, 1 or 2 and could not handle dosage. Therefore, in our analysis using
Mendel, for each individual we used the genotype with the highest posterior probabil-
ity at each SNP. We analyze the natural logarithm of plasma total IgE concentrations
as our phenotype (i.e., Y ) adjusted for smoking status (current, former and amount
of life time smoking in terms of pack-years), age, sex, and cohort of origin. A total
of 6975 participants (3209 men and 3766 women) age 19 and older had good quality
genotypes and were included in our analysis. Familial relationship was ignored when
applying our algorithm and the (Wu et al., 2009) approach, but we subsequently ap-
plied linear mixed effect models to account for familial correlation to obtain estimates
of effect sizes.
Some pre-processing was used to select a set of SNPs to include in our analysis.
First, we attempted to map each of the 2,411,590 genotyped and imputed SNPs in
the dataset to a reference gene containing it. If no such gene was available, then
we mapped the SNP to the closest reference gene within 60 kilobases of the SNP, if
available. Otherwise, the SNP was excluded. After establishing this mapping between
genes and SNPs, some genes were found to include multiple SNPs. We kept only one
SNP for each gene, selecting in each case the SNP most significantly associated with
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the phenotype, based on a linear mixed effect regression. As a result, the SNPs in the
final data set have low linkage disequilibrium (correlation) and a unique SNP-to-gene
correspondence. (As we will show in Section 4.1.4, our results reported below are
fairly robust to modest amounts of disequilibrium in these data.)
The final data set has 17, 025 SNPs/Genes. We used the KEGG (Kyoto Encyclo-
pedia of Genes and Genomes) pathway database to build our W matrix, following the
steps described in the Methods section of Chapter 2. The KEGG pathway database
has a total of 72, 354 genes and 5, 268 unique genes, resulting in 479, 066 interactions
allowed in our W matrix.
4.1.2 Results Using KEGG to Construct W Matrix
For our analysis on 17, 025 SNPs, we chose to look for 10 main effects, although we
allowed the algorithm to terminate after selecting 10 plus or minus one main effect,
resulting in 9 main effects selected in the current analysis. The parameter c was set
to 0.1 which, based on an average estimated SNP variance of 0.27 for these data,
corresponds to r ≈ 2.7. Six interactions were found in our approach, yielding a model
with a total of 15 = 9+6 variables. In order to calibrate our results with those from the
stage-wise procedure of (Wu et al., 2009), as implemented in Mendel, the latter was
run to select 9 variables in the first stage (i.e., fitting only main effects), and then 15
variables in the second stage (i.e., fitting both main effects and interactions, selected
from among the 9 SNPs resulting from the first stage). This process produced a final
model with 9 main effects and 6 interactions. In terms of computing time, our analysis
ran in roughly 5 minutes on our cluster Linga, equipped with 2 Intel Xeon CPUs E5345
@ 2.33GHz with 4 cores each and 16 GB / 32 GB of RAM for each node (the job
was submitted to one node and used one core), while the analysis in Mendel ran in
roughly 2 minutes. Given that our method evaluates 479, 066/55 ≈ 8710 times more
potential interactions than Mendel, the observed trade-off between computing time
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and number of possible interactions being evaluated appears to be quite reasonable.
The results from our proposed method and from the stage-wise procedure are
shown in the left and right, respectively, of Table 4.1. The estimates of effect size and
the ranks are from the linear mixed effect model for the final model after variable
selection procedure, for both methods. Genes previously found in a GWAS of these
FHS data (Granada et al., 2012) are indicated with an asterisk in the table. In our
approach, four of the six interaction pairs involved human leukocyte antigen (HLA)
genes, which encode antigen-presenting cell-surface proteins that are key regulators of
the immune response. The other two interactions identified were among genes both
previously associated with log IgE concentrations (Granada et al., 2012). In contrast,
Mendel did not detect any interactions among genes in the HLA regions or among
pairs of previously associated genes.
Table 4.1: Results of application to IgE concentration data.
Network-Guided Sparse Regression Mendel analysis
Gene1 Gene2 t-value Found Gene1 Gene2 t-value Found
FCER1A -5.6441 * LRP1 4.7084
MPP6 4.4184 SNF1LK2 4.3969
STAT6 -4.2453 * EMID2 -4.1795
IL13 4.0073 * RAB3C 3.8585
LRP1 3.7072 HLA-DQA2 3.6883 *
HLA-DPB1 HLA-DQA2 1.6314 FCER1A -2.8098 *
FCER1A HLA-DQA2 1.4193 HLA-DPB1 2.1346
HLA-G 1.3657 * LOC441108 1.9687
HLA-DPB1 1.1655 LOC441108 DDX1 1.7449
HLA-A 0.8442 * LRP1 DDX1 -1.6417
FCER1A IL13 0.6318 FCER1A SNF1LK2 -1.5967
HLA-DQA2 0.4590 * DDX1 SNF1LK2 -1.4047
HLA-A HLA-DPB1 0.4318 DDX1 -1.1802
HLA-G HLA-A -0.2813 HLA-DPB1 EMID2 0.8505
HLA-G HLA-DQA2 0.0678 HLA-DPB1 LOC441108 -0.8076
Terms are ranked based on absolute t value, * in found column represents the genes that were
found in publication.
From a biological perspective, a number of the interactions discovered by our
method are of nontrivial potential interest. The MHC class I antigens HLA-A, -B,
and -C are involved with cell-mediated immunity targeting cells expressing proteins
produced intracellularly, for example by viruses, while the MHC class II antigens
HLA-DP, -DQ, and -DR play key roles with humoral immunity, including the pro-
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duction of IgE antibodies directed against environmental allergens ((Klein and Sato,
2000)). HLA-G is a nonclassical MHC class I antigen that may have immunomod-
ulatory effects through actions on natural killer cells, T lymphocytes, and antigen-
presenting cells ((Carosella et al., 2008)). Genetic variants in these different classes of
HLA genes — each class influencing a different but interconnected aspect of immune
function — could well interact to influence the risk of developing IgE dysregulation
and allergy. The observed interaction between SNPs in the FCER1A and IL13 genes
may reflect a number of mechanisms. For example, a genetic variant causing in-
creased expression of FcεRIα on mast cells would lead to increased antigen-induced
activation of these cells, which would consequently produce more IL-13 ((Burd et al.,
1995)), leading to more class switch recombination and IgE production. Genetic
variation of FcεRIα on classical antigen-presenting cells may also promote Th2 cell
activation ((Potaczek et al., 2009)) with consequent IL-13 release. Thus, SNPs in
these two genes in the same pathway leading to increased IgE production could have
synergistic effects. Overall, identification of these interactions may help identify the
children at highest risk for developing allergy, possibly helping focus interventions to
prevent allergy, and may provide new insights into the genetic basis and mechanisms
of allergy.
4.1.3 Using Other Biological Databases
In the previous analysis, we used KEGG pathway database to construct our W matrix
to incorporate in the penalty. In order to see if there are additional interactions, we use
two other biological databases to construct the W matrix, GO (Gene Ontology) and
HPRD (Human Protein Reference Database) protein-protein interaction database.
KEGG database provides information on pathway and groups genes according to
the biochemical pathways they are involved in. GO database groups genes according
to biological functions (we used biological process collection). To construct the W
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matrix from GO, we use gene sets with less than 300 genes so that we include gene
sets with more specific biological functions, and follow the steps described in Chapter
2 Section 2.1.
On the other hand, HPRD database provides the information on protein-protein
interactions and the data consists of pairs of interacting genes. We use the gene pairs
as indicators of possible interactions and construct the W matrix by assigning the
indicators to the elements of the matrix.
For these two analyses, we used a more liberal set of parameters. We set to choose
30 main effects and the parameter c was set to 0.01 so that we could choose a fair
amount of interactions. Here the main purpose is to see if there are any potential
interesting interactions in addition to the main findings we obtained using the KEGG
pathway database.
The result of the analysis using GO database is shown in Table 4.2. Using a
different W matrix, we identified the same main effects found in the published GWAS
results of these FHS data (Granada et al., 2012), indicated with an asterisk in the
table. One of the interactions found is of potential interest given than both genes
(IL13 and HLA-G) have previously been identified.
The result of the analysis using HPRD PPI (protein-protein interactions) database
is shown in Table 4.3. Here we again found the same main effects reported in the
published GWAS result of the FHS data (Granada et al., 2012), indicated with an
asterisk in the table. Among the interactions found in this set of analysis, there is
one in the HLA region, and others involving the Interleukin genes IL13 and IL4R.
4.1.4 Effect of Linkage Disequilibrium
Another important issue to investigate is the effect of linkage disequilibrium (LD)
among SNPs, because regular Lasso methods assume unrelated predictors and do not
account for correlations among predictors. In our analysis of log plasma IgE con-
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Table 4.2: Results of application to IgE concentration using GO to
construct W matrix.
Using GO to construct W matrix
Gene1 Gene2 t-value Main effects Found
FCER1A -7.5568 *
SNFT -5.2928
HLA-DPB1 5.1444
DDX1 -4.6712
CDH11 4.4932
SNF1LK2 4.4436
EMID2 -4.3246
IL4R -4.2640
MPP6 4.2370
ANKS4B 4.2282
LOC441108 4.1518
PPP2R2B 4.1266
CST5 -4.0151
C6orf85 3.9109
TLN2 3.8613
HLA-DRB1 -3.8140
LRP1 3.7417
STAT6 -3.7026 *
HAND1 -3.6482
GREM2 -3.5610
AMDHD1 -3.4063
RAB3C 3.3114
CMA1 -3.1356
TRPM6 3.0290
IL13 2.4194 *
HLA-G HCP5 1.9078
HLA-A 1.5245 *
IL13 HCP5 1.4447
HCP5 1.1852
IL13 HLA-G 1.1163
HLA-DQA2 0.9184 *
HLA-G -0.0546 *
centrations, we select 1 SNP per gene to decrease correlation between SNPs. Here
we perform three more analyses by selecting 1 SNP, 3 SNPs or 5 SNPs per gene,
respectively. W matrices for the analyses are constructed using the KEGG pathway
database. All three analyses are restricted to Chromosome 6, i.e., where the previ-
ously identified main effects and interactions are concentrated, since our focus here
is not so much on the discovery of additional interactions, but rather on assessing
the robustness of our previous findings when some degree of LD exists. We set the
tuning parameters the same way as we did when using the KEGG pathway database
57
Table 4.3: Results of application to IgE concentration using HPRD
PPI to construct W matrix.
Using HPRD PPI to construct W matrix
Gene1 Gene2 t-value Main effects Found
FCER1A -7.535390555 *
SNFT -5.27318176
HLA-DPB1 5.137494999
IL13 4.803813165 *
DDX1 -4.703033381
CDH11 4.536470905
SNF1LK2 4.476663127
EMID2 -4.340102709
MPP6 4.24129508
ANKS4B 4.177733918
LOC441108 4.118810407
STAT6 -4.070155021 *
PPP2R2B 4.068292492
CST5 -4.04076742
C6orf85 3.901504818
TLN2 3.787433938
LRP1 3.7574075
HAND1 -3.663633263
GREM2 -3.546774073
AMDHD1 -3.42627879
IL4R -3.425851751
RAB3C 3.414224153
HCP5 3.369049934
CMA1 -3.111652119
TRPM6 3.012148241
STAT6 IL4R 1.668298955
HLA-A 1.504116975 *
HLA-G 1.491234609 *
HLA-DRB1 -1.174091022
IL13 IL4R -1.148257656
HLA-DRA -0.946271115
HLA-DQA2 0.899191618 *
HLA-DRA HLA-DRB1 -0.258048129
in Section 4.1.2 for all three analyses. Specifically, λ1 is set to select 10 main effects
and c is set to 0.1.
The results from these analyses are shown in Table 4.4. The two analyses with
3 SNPs per gene and with 5 SNPs per gene have selected exactly the same main
effects and interactions in terms of genes, so we present their results as one, in com-
parison to the analysis with 1 SNP per gene. From the table we can see that the
one-SNP/gene analysis and the 3&5-SNP/gene analyses selected many of the same
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main effects/interactions at the gene level. Furthermore, there is substantial instances
of gene-level main effects and interactions found in the 3& 5-SNP analyses, due to
the selection of multiple SNPs per gene. More specifically, in terms of main effects,
the one-SNP/gene analysis found 11 main effects, while the 3& 5-SNP/gene analyses
found 7 unique main effects (11 non-unique), 6 of which were among those found by
the one-SNP/gene analysis. Similarly, the one-SNP/gene analysis found 14 interac-
tions, and the 3& 5-SNP/gene, 15 interactions (32 non-unique), with 6 interactions in
common. Combining main effects and interactions, the corresponding Jaccard coef-
ficient was 12/23 = 0.522. (The Jaccard coefficient measures similarity between two
sample sets, and is defined as the size of the intersection divided by the size of the
union of the sample sets.)
In summary, the effect of modest LD among SNPs has not seemed to substantially
affect the selection of terms in this example.
4.2 Application to CRP Serum Levels
4.2.1 Background
We apply our method to evaluate gene-by-gene interactions influencing C-reactive
protein serum levels. C-reactive protein (CRP) is a general marker of systemic in-
flammation. High CRP levels are associated increased risks of mortality and major
disease including diabetes mellitus, hypertension, coronary heart disease and stroke.
CRP is also a heritable marker of chronic inflammation that is strongly associated
with cardiovascular disease. Eighteen loci associated with CRP levels have been iden-
tified to be associated with CRP levels (Dehghan et al., 2011). But interactions have
not been identified yet and we are interested in looking at gene-by-gene interaction
associated with CRP levels using the Framingham Heart Study data.
This analysis has 6899 participants which include 3221 men and 3678 women with
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age 19 and older, 3852 from the Offspring cohort and 3047 from the third generation
cohort. We analyze the natural logarithm of CRP serum levels as our phenotype,
adjusted for age and sex.
We ignore familial relationship when applying our algorithm and account for the
relatedness subsequently using a linear mixed effect model. We perform the same
pre-processing to select a set of SNPs such that only one SNP is kept for each gene
and the SNPs in the final data set have low linkage disequilibrium and a unique SNP-
to-gene correspondence. The final data set has 17,569 SNPs/Genes. As we already
saw from the first application, KEGG was more effective in finding interactions than
GO and HPRD databases. So for this application, we used only KEGG pathway
database to construct W matrix, which allowed 499,687 interactions to be evaluated
by the algorithm.
4.2.2 Results
For this analysis, we choose to look for 30 main effects and set parameter c to 0.01.
We allow the algorithm to terminate after selecting 30 plus or minus one main effects.
The analysis selects 29 main effects and 4 interactions. The selected terms are ranked
according to their absolute t values in the final fitting, and shown in Table 4.5. Genes
previously identified in (Dehghan et al., 2011) are indicated with an asterisk in the
table. We find 6 main effects that were previously identified (Dehghan et al., 2011),
one (out of 4) interaction in genes both previously associated with log CRP levels,
and another two interactions involving one of the previously reported genes.
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4.3 Application to Fasting Glucose
4.3.1 Background
Fasting Glucose is commonly measured to detect type II diabetes and is one of the
criteria that defines type II diabetes. Some new genetic loci have been identified to be
associated with fasting glucose in a recent meta-analysis (Dupuis et al., 2010; Manning
et al., 2012). As a third application of our method, we are interested in investigating
interactions among these newly discovered genes using Framingham Heart Study.
This analysis includes 6479 participants (2981 men and 3498 women, with age
19 and older), 2766 from the Offspring cohort and 3713 from the third generation
cohort. We analyze the fasting glucose as our phenotype adjusted for age, sex, bmi
and cohort of origin.
We again ignore familial relationship when applying our algorithm and account
for relatedness in subsequent analysis using linear mixed effect model. We perform
the same pre-processing to select a set of SNPs such that only one SNP was kept for
each gene and the SNPs in the final data set have low linkage disequilibrium and a
unique SNP-to-gene correspondence. The final data set has 17,026 SNPs/Genes. For
this application, we also used only KEGG pathway database to construct W matrix,
which allowed 479,252 interactions to be evaluated by the algorithm.
4.3.2 Results
For the analysis of fasting glucose, we chose to look for 30 main effects and set param-
eter c to 0.01. We allowed the algorithm to terminate after selecting 30 plus or minus
one main effects. The analysis selected 31 main effects and 6 interactions. Results of
selected terms are ranked according to their absolute t values in the final fitting, as
shown in Table 4.6. Gene previously found in (Dupuis et al., 2010) are indicated with
an asterisk in the table. We found three main effects that were previously identified,
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one (out of six) interaction in genes both previously associated with fasting glucose
(Dupuis et al., 2010) and another interaction involving one of the previously reported
genes.
4.4 Summary
In this chapter, we applied our proposed method to three real data sets in Framing-
ham Heart Studies. For the first application of log IGE concentration, we used three
different biological databases to construct W matrix KEGG pathway, GO biological
process collection and HPRD protein-protein interactions database. Using the KEGG
pathway database, we found 6 potentially biologically meaningful gene-by-gene inter-
actions. The analyses using GO and HPRD databases added a couple additional
such interactions. In all of the three analyses, we replicated 6 genes as main effects
that were previously identified in (Granada et al., 2012). We also used stage-wise
method implemented in Mendel to investigate the gene-by-gene interactions, but it
didn’t find any potentially interesting interactions and only replicated two previously
found genes in main effects.
Using the IGE dataset as an example, we also investigated the performance of our
method under modest LD. We selected 1, 3, 5 SNPs per gene for SNPs on Chromosome
6 and compared the three analyses. The analyses with 3 SNPs and 5 SNPs per gene
selected the same list of main effects and interactions on gene levels. We also compared
the one-SNP/gene analysis and the 3&5-SNP/gene analyses. In terms of the unique
main effects and interactions, the effect of modest LD among SNPs did not seem to
substantially affect the selection of terms (with Jaccard coefficient of 0.522).
We applied the method to two more data sets in Framingham Heart Study, CRP
serum levels and Fasting Glucose. We used only KEGG pathway database to con-
struct W matrix, since we can see that in the first example using KEGG pathway is
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more effective in finding interesting interactions. The results of these two analyses
also found some interactions involving pairs of previously identified genes.
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Analysis with 1 SNP per gene Analysis with 3 SNP, or 5 SNP per gene
Gene1 Gene2 t-value Gene1 Gene2 t-value
GABRR2 -3.8654 C6orf85 3.8465
C6orf85 3.661 HLA-DPB1 HLA-DPB1 -2.5109
HCP5 2.7668 HLA-A HLA-DPB1 -2.5054
ITPR3 -2.7008 HLA-DPB1 2.2225
HLA-G HLA-DRB1 -2.1174 HLA-DPB1 HLA-DPB1 2.221
HLA-G 1.7588 HLA-G HLA-DQB1 -2.1499
HLA-DRA HLA-B -1.6056 HLA-B 1.9161
HLA-DQA2 HLA-DPB1 1.3734 HLA-G HLA-DQA2 -1.8227
HLA-DPB1 1.332 HLA-G HLA-DQA2 1.5974
HLA-DRA HLA-A 1.1896 HLA-A HLA-DQA2 1.5698
HLA-G HLA-B -0.8313 HLA-A HLA-DQA2 1.5636
HLA-DRA -0.755 HLA-DPB1 HLA-DPB1 1.3393
HLA-DQA2 HLA-DRB1 -0.7169 HLA-DQA2 HLA-DQB1 -1.3266
HLA-B HLA-DPB1 -0.6759 HLA-DQA2 HLA-DPB1 -1.1567
HLA-A HLA-DRB1 0.6391 HLA-DQA2 HLA-DPB1 1.053
HLA-DRA HLA-DQA2 0.6107 HLA-A HLA-G 1.0475
HLA-G HLA-DQA2 -0.6104 HLA-A HLA-G 1.0326
HLA-DRA HLA-DRB1 -0.2642 HLA-DPB1 -0.8669
HLA-DPB1 HLA-A 0.2427 HLA-A HLA-DPB1 -0.8565
HLA-A 0.0869 HLA-G HLA-DPB1 -0.8522
HLA-B HLA-DQA2 0.0459 HLA-A HLA-A -0.8375
HLA-DRB1 -0.0416 HLA-DQA2 -0.7843
HLA-G HLA-A -0.033 HLA-A HLA-DQB1 0.7532
HLA-B -0.0313 HLA-B HLA-DPB1 0.7229
HLA-DQA2 0.0261 HLA-G HLA-B 0.6769
HLA-A HLA-DQB1 -0.6027
HLA-A HLA-DPB1 -0.4971
HLA-A HLA-G -0.4673
HLA-G HLA-B -0.4622
HLA-A -0.4584
HLA-G HLA-G 0.4567
HLA-DQB1 -0.3608
HLA-B HLA-DPB1 0.3006
HLA-DPB1 0.2888
HLA-A 0.2234
HLA-G HLA-DQB1 0.2223
HLA-A HLA-DPB1 -0.1681
HLA-A HLA-DPB1 -0.1242
HLA-A HLA-DPB1 -0.1175
HLA-G -0.0746
HLA-A HLA-G -0.0638
HLA-B HLA-DQB1 -0.0413
HLA-G -0.0276
Table 4.4: Results of application to IgE concentration data, with
varying LD among SNPs. Terms are ranked based on absolute t value.
Blue: genes / interactions found only in one-SNP/gene analysis; Purple:
genes / interactions found only in 3&5-SNPs/gene analyses; Red: genes
/ interactions found in all three analyses.
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Table 4.5: Results of application to CRP.
Network Guided Sparse Regression for CRP
Gene1 Gene2 t-value Main effects Found
CRP -8.018683534 *
LEPR -5.00387017 *
FLJ43860 -4.363210157
RAD23B 4.250179466
C9orf30 -4.142057122
ETAA1 4.087399338
RGS6 4.051728602 *
IFLTD1 -4.027429023
TDRD10 -3.955953323
TMEM132D 3.95507514
MCART2 3.948868622
SCN3B -3.926474997
SLC24A4 -3.921758746
GCKR 3.891738579 *
VIT 3.881651071
GDNF -3.737491061
NR3C2 3.708207987
NEBL 3.648881857
NOTCH4 -3.5771008
PDE8B 3.557864712
COPS5 3.503856221
MANSC1 3.238662051
NHLRC1 2.686591709
IL1R2 -2.552375629
UGT3A2 -2.521693083
HNF1A -2.493997014 *
SKP2 1.799122844
IL6R -1.71177651 *
OASL -1.657445141
LEPR IL6R 1.262566345
IL6R IL1R2 -0.861904991
LEPR IL1R2 0.854238003
NHLRC1 SKP2 -0.079797391
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Table 4.6: Results of application to Fasting Glucose.
Network Guided Sparse Regression for Fasting Glucose
Gene1 Gene2 t-value Main effects Found
MTNR1B 6.597569199 *
CDKL1 4.910601399
TTYH2 4.863204072
C1orf201 4.637364714
ABCB11 4.614830018
ARHGEF7 -4.483844169
PARVB -4.455953222
NSUN2 -4.366593041
G6PC2 -4.34652349 *
GCK 4.264128274 *
ATXN7L1 4.221013512
EVL 4.215670293
FLJ46082 4.139703081
RBMXL2 4.118967855
STK40 4.080306367
C4orf6 4.069766781
PDGFRL 4.003454714
RARB -3.993516861
ASAH1 -3.965690824
TOM1L1 3.878585464
KCNJ1 3.86017897
PARD3 3.840674359
SLC8A3 -3.704740594
ZNF793 3.702417636
SNX7 3.566606658
NFATC2 3.532683466
CNTN4 3.515837319
MEST 3.437653132
MAGI2 -2.782542891
SPC25 2.587174283
PARD3 ZAK -2.465609064
MTNR1B PARD3 -1.803288774
PARD3 MAGI2 0.547763814
ZAK MAGI2 -0.532970004
ZAK NFATC2 -0.462383518
G6PC2 GCK 0.372561933
ZAK 0.001314428
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Chapter 5
Conclusion
We developed a novel methodology to detect gene-by-gene interactions. We assessed
the performance of this method under various scenarios in simulation, and compared
it to a stage-wise competitor. The simulations showed that our method outperforms
the competitor in finding true interactions, while maintaining about the same ability
to detect main effects. Our method is robust to the inclusion of ‘noise interactions’ be-
tween non-active SNPs. As showed in simulation, scaling up the number of predictors
didn’t adversely affect our ability to detect interactions if the increased predictors are
not involved in interactions. But it performs less well when ‘noise interactions’ involve
true active SNPs. Incorporating outside biological information as a network induced
in the penalty term is an advantage of our method, in both reducing computing time
and guiding selection of interactions. Additional simulations also showed that our
method outperforms the simple association tests in detecting both interactions and
main effects.
To extend our method to multi-cohort setting, we evaluated four procedures to
conduct meta-analysis in simulations and found the approach that performs most
closely to the mega-analysis which consists of merging individual level data are merged
together and analyzing as one dataset. This procedure (B) is also more practical
because it splits cohorts instead of splitting data within each cohort and thus simplifies
the communication process among different study centers and reduce the possibility
of making errors.
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Another advantage of Procedure B is that, it is relatively easy to implement
multiple splits compared to other procedures. As stated in Chapter 3, all studies
would be requested to perform variable selection analysis only once. The multiple
splits of cohorts is conducted on the meta-analyst’s side and only affects the union
lists of selected terms that may be generated by different assignments of studies in
the first group. On the side of individual cohorts, they are asked to perform at most
K final model fittings based on their assignment of groups after the variable selection
analysis, where K is the number of splits. But for other procedures, for example,
Procedure C, it is a much more complicated process. Each cohort would need to
split their data K times, perform variable selection K times and final model fitting
K times. This is an error-prone process because the meta-analysis center has much
less control over the analysis. We recommend using Procedure B when conducting
meta-analysis using our method.
Our meta-analysis approach is generalizable to other penalized regression meth-
ods, as the feature of our method that is used to develop the meta-analysis approach
is no different than any other Lasso-based method.
We applied our proposed method to real datasets in Framingham Heart Study.
As a typical example using KEGG pathway database to construct W matrix in the
penalty, the IGE analysis showed that we found some potentially biologically inter-
esting interactions and were able to identify many important main effect findings
previously reported in publications as well. We explored the detection of interactions
using two other outside biological sources GO and HPRD PPI database. These two
analyses identified two additional interactions that are potentially interesting, one
in pairs of previously identified genes and the other in the HLA region. We tested
our method under modest LD using the IGE data and found that including multiple
SNPs per gene did not substantially affect the result. We further applied our method
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to another two real data sets, CRP serum levels and fasting glucose. Using KEGG
pathway database to construct W matrices for these two analyses, we found some in-
teractions that may be interesting for these two phenotypes (one interaction in each
analysis having genes both previously found).
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Appendix A
A.1 Derivation of Model Fitting Algorithm
Our goal is to optimize the objective function
f(β) =
1
2
(
Y −
p∑
j=1
Xjβj −
p∑
k>j
Xjkβjk
)T (
Y −
p∑
j=1
Xjβj −
p∑
k>j
Xjkβjk
)
+ λ1
p∑
j=1
(w2jj‖Xjβj‖2 +
p∑
k:k 6=j
w2jk‖Xjkβjk‖2)1/2 + λ2
p∑
j=1
p∑
k>j
wjk‖Xjkβjk‖
(A.1)
in β = {{βj}, {βjk}}, where Y = (Y1, . . . , Yn)T , Xj = (X1j, . . . , Xnj)T , and Xjk =
(X1jX1k, . . . , XnjXnk)
T . Without loss of generality, we assume that Y and {Xj}pj=1
have been centered about their mean and standardized to have unit norm (and, in-
deed, our computations have been done under this convention). However, all key
formulas below are derived in fully un-standardized form, for consistency across
variables, since standardization of Xj does not imply standardization of Xjk (i.e.,
||Xjk|| 6= 1).
To accomplish our optimization, we use a coordinate descent algorithm, which
updates one element of β at a time while holding all other elements fixed and cycles
through all elements until convergence. We describe the resulting one-dimensional
optimizations separately for the main effects and for the interaction effects.
Consider the main effect coefficient βj. It is convenient to write the optimization
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with respect to this coefficient as
min
βj
1
2
(
Y˜j −Xjβj
)T (
Y˜j −Xjβj
)
+ λ1
(
w2jj||Xjβj||2 + cj
)1/2
+ Cj , (A.2)
with cj =
∑
k 6=j w
2
jk||Xjkβjk||2 and
Y˜j = Y −
∑
`6=j
X`β˜` −
p∑
`=1
∑
k>`
X`kβ˜`k , (A.3)
where β˜` is the current value of β`, β˜`k is the current value of β`k, and Cj is all of the
rest of the penalty that does not involve βj. Let βˆj denote the OLS estimator from
fitting a regression through the origin for Y˜j on Xj. Having centered and rescaled
our variables, it follows that βˆj = X
T
j Y˜j and that (A.2) may be re-expressed as
min
βj
1
2
||Xj||2
(
βˆj − βj
)2
+ λ1
(
w2jj||Xjβj||2 + cj
)1/2
+ C ′j . (A.4)
Differentiating the argument in (A.4) with respect to βj and setting the result to zero
yields
∂
∂βj
= ||Xj||2
(
βj − βˆj
)
+
λ1w
2
jj||Xj||2βj
(w2jj||Xj||2β2j + cj)1/2
= 0 . (A.5)
So our estimate β˜j of the main effect of interest, βj, is the solution to
βj
(
1 +
λ1w
2
jj
(w2jjX
T
j Xjβ
2
j + cj)
1/2
)
= βˆj . (A.6)
Hence our solution has the form β˜j = αjβˆj, for some shrinkage parameter αj ∈ [0, 1],
where αj satisfies the equation
αj
(
1 +
λ1w
2
jj
(w2jjX
T
j Xjα
2
j βˆ
2
j + cj)
1/2
)
= 1 . (A.7)
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When cj = 0, (A.6) can be solved in closed form as
β˜j = sign(βˆj)
(
|βˆj| − λ1wjj/(XTj Xj)1/2
)
+
,
where (·)+ denotes ‘positive part’.
Similarly, to estimate interaction coefficients {βjk} we write the optimization with
respect to, say, βjk as
min
βjk
1
2
(
Y˜jk −Xjkβjk
)T (
Y˜jk −Xjkβjk
)
+ λ1
p∑
`=1
(w2``‖X`β`‖2 +
p∑
m:m 6=`
w2`m‖X`mβ`m‖2)1/2 + λ2
p∑
`=1
p∑
m>`
w`m‖X`mβ`m‖
(A.8)
where
Y˜jk = Y −
p∑
`=1
X`β˜` −
∑
m>`
∑
(`,m)6=(j,k)
X`mβ˜`m . (A.9)
The optimization (A.8) can be rewritten as
min
βjk
1
2
XTjkXjk(βˆjk − βjk)2 + λ1
p∑
`=1
(w2``‖X`β`‖2 +
p∑
m:m6=`
w2`m‖X`mβ`m‖2)1/2
+ λ2
p∑
`=1
p∑
m>`
w`m‖X`mβ`m‖
(A.10)
where βˆjk = X
T
jkY˜jk/X
T
jkXjk is the OLS estimator from fitting a regression through
the origin of Y˜jk on Xjk.
Reasoning as in the case of main effects, differentiating the argument in (A.10)
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with respect to βjk and setting the result to zero yields
∂
∂βjk
=XTjkXjk(βjk − βˆjk)
+ λ1
w2jkX
T
jkXjkβjk
(w2jjX
T
j Xjβ
2
j +
∑
m6=j w
2
jmX
T
jmXjmβ
2
jm)
1/2
+ λ1
w2jkX
T
jkXjkβjk
(w2kkX
T
kXkβ
2
k +
∑
m6=k w
2
kmX
T
kmXkmβ
2
km)
1/2
+ λ2wjk(X
T
jkXjk)
1/2sign(βjk)
= 0
(A.11)
which can be simplified to
β˜jk
(
1 + λ1w
2
jk[
1
(w2jkX
T
jkXjkβ˜
2
jk + c
jk
1 )
1/2
+
1
(w2kjX
T
kjXkjβ˜
2
kj + c
jk
2 )
1/2
]
)
= sign(βˆjk)(|βˆjk| − λ2wjk(XTjkXjk)−1/2)+
(A.12)
or
αjkβˆjk
(
1 + λ1w
2
jk[
1
(w2jkX
T
jkXjkα
2
jkβˆ
2
jk + c
jk
1 )
1/2
+
1
(w2kjX
T
kjXkjα
2
jkβˆ
2
jk + c
jk
2 )
1/2
]
)
= sign(βˆjk)(|βˆjk| − λ2wjk(XTjkXjk)−1/2)+
(A.13)
Here cjk1 = w
2
jjX
T
j Xjβ
2
j +
∑
m 6=j,k w
2
jmX
T
jmXjmβ
2
jm and
cjk2 = w
2
kkX
T
kXkβ
2
k +
∑
m6=k,j w
2
kmX
T
kmXkmβ
2
km, while αjk ∈ [0, 1] is a shrinkage param-
eter defining β˜jk = αjkβˆjk. Solving (A.13) for αjk yields β˜jk.
Based on the calculations above, the coordinate descent algorithm optimizing
(A.1) is:
Algorithm:
1. initialize β˜j and β˜jk for all j, k ∈ {1, . . . , p},
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2. for j ∈ {1, . . . , p},
compute Y˜j = Y −
∑
6`=j X`β˜` −
∑p
`=1
∑
k>` X`kβ˜`k;
compute βˆj = X
T
j Y˜j;
solve (A.7) for shrinkage parameter αj;
update β˜j = αjβˆj.
3. for (j, k) ∈ 1 ≤ j ≤ k ≤ p,
compute Y˜jk = Y −
∑p
`=1 X`β˜` −
∑
m>`
∑
(`,m)6=(j,k) X`mβ˜`m;
compute βˆjk = X
T
jkY˜jk/X
T
jkXjk;
solve (A.13) for shrinkage parameter αjk;
update β˜jk = αjkβˆjk.
4. iterate steps 2 and 3 until convergence.
A.2 Optimizing the Algorithm
Despite the fact that our algorithm replaces the original high-dimensional optimiza-
tion in (A.1) with an iteration over a collection of simpler, one-dimensional opti-
mizations, and despite the expected efficiencies to be gained through use of an ap-
propriately sparse matrix W = [wjk], application of the algorithm to datasets with
large numbers of SNPs (e.g., millions or tens of millions) will still be computationally
prohibitive. Therefore, in order to accelerate the algorithm, we employ a ‘swindle’,
similar to that of Wu et al. (2009). The basic idea is to apply the algorithm to only
a small, well-chosen subset of SNPs, thus estimating the coefficients βj and βjk for
those SNPs, and to treat the coefficients of all other SNPs as zero. This estimate
is then checked as a solution to the full optimization problem, by direct evaluation
of the Karush-Kuhn-Tucker (KKT) conditions corresponding to (A.1). If the KKT
conditions are satisfied, we are done. If not, the subset of SNPs upon which our
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algorithm is run is expanded, and we repeat the process. The SNPs are ordered for
inclusion in this process according to an appropriate scoring function.
In more detail, our approach is as follows. We define an initial score for each
predictor in the form
scorej =
∣∣∣∣∣
n∑
i=1
yixij
∣∣∣∣∣ , (A.14)
which captures the extent to which the phenotype Y is correlated with the j-th
SNP (the data are assumed to be centered and scaled). Recall that our smoothing
parameter λ1 is chosen implicitly, by the user specifying a desired number s of main
effects to be included in the model. For a given s, we extract those k > s predictors
with the largest scores, where k is a multiple of s (e.g., taken to be k = 10s in all
of our implementations). The algorithm described above is applied to this subset
of k predictors, yielding estimates of coefficients βj for s main effects, as well as any
interactions allowed to enter the model. Coefficients of zero are assigned to any of the
k predictors that did not enter the model, to any interactions among the k predictors
that similarly did not enter the model, and to the main effects and interactions
involving any predictors not among the k on which the algorithm was applied.
Let
L(β) =
1
2
(Y −
p∑
j=1
Xjβj −
p∑
k>j
Xjkβjk)
T (Y −
p∑
j=1
Xjβj −
p∑
k>j
Xjkβjk) (A.15)
denote the least-squares term in (A.1). The coefficients obtained for the k predic-
tors used in the algorithm, both main effects and interactions, will satisfy the KKT
conditions. It remains to examine whether the zeros assigned as coefficients for all
predictors not used in the algorithm satisfy the KKT conditions as well. Direct cal-
culation and examination of the resulting equations yields that the relevant KKT
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conditions for the optimization in (A.1) are the following:
βj = 0 ⇒ |OL(β)j| ≤ λ1wjj(XTj Xj)1/2, given βjk = 0 (A.16)
βjk = 0 ⇒|OL(β)jk| ≤ (2λ1 + λ2)wjk(XTjkXjk)1/2,
given βj = 0, βk = 0, βjm = 0 for all m 6= k and βkm = 0 for all m 6= j
(A.17)
βjk = 0 ⇒|OL(β)jk| ≤ (λ1 + λ2)wjk(XTjkXjk)1/2,
given βj = 0, βjm = 0 for all m 6= k; or βk = 0, βkm = 0 for all m 6= j
(A.18)
Here OL(β)j and OL(β)jk are the derivatives of L(β) respect to βj and βjk, respec-
tively.
We check conditions (A.16,A.17,A.18) for the omitted predictors and interactions.
If the conditions are satisfied we stop and the result is a global minimum. If any of the
omitted predictors and interactions violate the conditions, we double k and repeat the
process until the conditions are satisfied. The KKT conditions are satisfied eventually
since in the worst case k equals the total number of predictors. However, in practice
our experience is that with the choices of s and k used in our work (e.g., s = 20 or
30, and k = 10s) the algorithm typically doubles few times if any.
A.3 Selection of Tuning Parameters
Our proposed method has two tuning parameters: λ1 and λ2. Recall that λ1 is set
implicitly in our approach, through the user specifying a desired number of main
effects to be kept in the model. In addition, recall that we reparameterize λ2 in terms
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of λ1, as λ2 = cλ1. Here we describe the derivation of a heuristic for choosing c in
a manner that is informed by the extent to which interactions can enter the model
relative to main effects.
Consider a specific main effect, βj, and an interaction effect, βjk. In order to
better focus the exposition squarely on c and its connection to interactions, we will
here explicitly utilize our assumption that ||Xj|| = 1, which allows us to drop all
such terms from the expressions below. By examining the equations for αj (A.7) and
αjk (A.13), we can obtain thresholds of unshrunken estimates for the corresponding
terms Xj and Xjk to enter the model. Specifically, for main effects,
threshold for Xj to enter =

λ1wjj , if βjk = 0 for all k
0 , otherwise
(A.19)
whereas for interactions βjk,
threshold for Xjk to enter
=
wjk
(XTjkXjk)
1/2

λ2 + 2λ1 , if βj = βk = 0
λ2 + λ1 , if βj 6= 0 or βk 6= 0
λ2 , if βj 6= 0 and βk 6= 0 .
(A.20)
Having reparameterized λ2 = cλ1, (A.20) can be reexpressed as
the threshold for Xjk to enter
=
λ1wjk
(XTjkXjk)
1/2

c+ 2 , if βj = βk = 0
c+ 1 , if βj 6= 0 or βk 6= 0
c , if βj 6= 0 and βk 6= 0 .
(A.21)
Suppose that we parameterize by r the relative difficulty of a main effect entering
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a model as compared to an interaction. Then the expressions in (A.19) and (A.21)
suggest (ignoring the distinction between c, c+ 1, and c+ 2 in (A.21)) setting
r =
λ1wjj
cλ1wjk/(XTjkXjk)
1/2
=
wjj
wjk
(XTjkXjk)
1/2
c
, (A.22)
and hence
c =
wjj
wjk
(XTjkXjk)
1/2
r
. (A.23)
The choice of c therefore will vary inversely with the value r specified by the user.
In addition, it will be influenced directly by the ratio of the values wjj and wjk, i.e.,
the weights in the matrix W associated with βj and βjk in the penalty function in
the optimization (A.1). If a W matrix with ones down the diagonal is used, as we
do, then wjj = 1, and so only the value wjk plays an explicit role in setting c. If a
choice is made to use a binary matrix W , as we do in our simulations, then wjk = 1.
In that case, the value of c is driven purely by (a) the user-specified value of r, and
(b) the value (XTjkXjk)
1/2.
In order to interpet this term, we reason as follows. Recall that we have centered
the Xj and rescaled them so that ‖Xj‖ = 1. Let Uj,i be the original observation for
individual i on predictor j after centering but before rescaling, then it has (approxi-
mately) mean zero and, say, variance σ2j . Asymptotically, we have
Xj,i ≈ 1√
nσj
Uj,i . (A.24)
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Since Xj,k is obtained through elementwise multiplication of Xj and Xk,
XTjkXjk ≈
1
nσjσk
UTjiUjk
1
nσjσk
n∑
i=1
Ujk,iUjk,i
1
nσjσk
n∑
i=1
U2j,iU
2
k,i . (A.25)
Now under an assumption of independence of predictors (i.e., independence of SNPs),
we know that
E(U2j,iU
2
k,i) = E(U
2
j,i)E(U
2
k,i) = σ
2
jσ
2
k .
Assuming furthermore independent individuals, we have therefore by SLLN that
XTjkXjk −→ σjσk. Therefore we have (XTjkXjk)1/2 ≈ (σjσk)1/2.
In other words, the term (XTjkXjk)
1/2 in (A.23) can be expected to behave (roughly)
like the product of standard deviations of SNPs j and k. Because, for simplicity, we
wish to use a single value c for all interactions βjk, in practice we use the mean or
median (for our data, the difference was negligible) value of (XTjkXjk)
1/2 across SNP
pairs for all pairs. Writing the SNP variance as σ2j = 2pij(1 − pij), where pij is the
minor allele frequency for SNP j, the distribution of these terms can be calculated
efficiently by first calculating the σj values and then their products (for all j, k pairs
with non-zero entry wjk).
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